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INTRODUCTION 
 
Obesity is defined by an excessive fat deposition which can be deleterious for the health. Obesity is 
often the result of an energy input excess and/or a decrease in energy expenditure.
 
The World 
Health Organisation estimates that 10% of the world population is obese today
1
.
 
This imbalance can be explained by an increased intake of hyper caloric food and a sedentary 
lifestyle with motorized transport and many labour-saving devices, as well as other physically-
inactive pursuits (TV viewing, computering etc.)
2, 3
.   
Since obesity rates are high, the continuous efforts made by the scientific community are warranted 
in order to further elucidate the origin and the cause of obesity, which involves neuroendocrine and 
genetic components, in addition to lifestyle factors. 
The high precision of body-weight regulation is achieved by a number of integrated homeostatic 
systems which adjust or match the energy balance constituents. 
Three main factors appear to participate in body weight maintenance: metabolic utilization of 
nutrients, dietary habits and physical activity.  
 
The obesity is often associated with the metabolic syndrome.  
International Diabetes Federation in 2007 defined the metabolic syndrome as an increase in 
abdominal circumference associated with two of these factors: 
Arterial blood pressure               ˃130/85mmHg  
Fasted triglyceridemia               ˃ 150 mg/dl 
Fasted HDL cholesterolemia     ˃40mg/dl for the man and inferior 50 for the woman 
Fasted glycemia                         ˃5.5 mmol/L 
 
The metabolic syndrome is a cluster of different metabolic defects, characterized by an obesity and 
an insulin resistance. 
 
The insulin resitance (IR) is the condition in which normal amounts of insulin are inadequate to 
produce a normal insulin response in fat, muscle and liver cells. In this case there is an increase in 
hepatic glucose production, a decrease of glucose uptake and an increase in lypolisis . All these 
effects lead to an increased glycemia.  
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Insulin resistance in fat cells reduces the effects of insulin and results in elevated hydrolysis of 
stored triglycerides in the absence of intervention which either increase insulin sensitivity or 
provide additional insulin. Increased mobilization of stored lipids in adipocytes elevates free fatty 
acids in the blood plasma.  Elevated blood fatty-acid concentrations (associated with insulin 
resistance and diabetes mellitus Type 2), reduced muscle glucose uptake, and increased liver 
glucose production all contribute to elevated blood glucose concentration. 
Insulin resistance in muscle cells reduces glucose uptake (and so local storage of glucose as 
glycogen), whereas insulin resistance in liver cells results in impaired glycogen synthesis and a 
failure to suppress glucose production.  
High plasma levels of insulin and glucose due to insulin resistance are believed to be at the origin of 
metabolic syndrome and type 2 diabetes, including its complications. 
 
Liver is an essential organ in energy metabolism. It plays a role in carbohydrate metabolism, 
producing glucose and storing it massively as glycogen. It also plays a major role in lipid 
metabolism. In fact it synthetizes cholesterol and triglygerides (TG), it produces and recycles 
lipoproteins and can store lipid into TG. However in healthy human, lipid content in liver is low and 
represents only 5% of total liver weight. In obese individuals these levels are exceeded and lead to 
hepatic steatosis.   
Insulin resistance and visceral obesity are associated with the development of Non Alcoholic Fatty 
Liver Disease (NAFLD). When insulin resistance develops, free fatty acids are inappropriately, or 
ectopically shifted to nonadipose tissues, including the liver. 
 NAFLD includes a spectrum of hepatic pathologies that resembles alcohol-induced liver diseases 
but develops in individuals who are not heavy drinkers (10) 
4
 and NAFLD is now considered as the 
hepatic manifestation of the metabolic syndrome.  
NAFLD is a TG accumulation in hepatocytes and this condition can progress into a hepatic steatosis 
with inflammation (Non AlcholicSteatoHepatitis or NASH), fibrosis, cirrhosis and in the most 
severe cases, into hepatocarcinoma 
5
. 
Insulin resistance in fact increases free fatty acid flux to the liver by decreased inhibition of 
lipolysis in adipose tissue and also by increased hepatic de novo lipogenesis
6
. 
 
Apoptosis and oxidative stress may also contribute to the development and progression of NAFLD 
into more serious pathologies. 
Recently, mitochondrial disfunctions have been involved in insulin resistance and hepatic steatosis. 
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Addiotionally insulin resistance and visceral obesity also result in decreased levels of a “protective 
adipokine,” adiponectin. Adipokine or factors secreted by adipose tissue can regulate insulin 
sensitivity Adiponectin inhibits liver gluconeogenesis and suppresses lipogenesis. Thus, decreased 
adiponectin hinders fatty acid oxidation and increases fat accumulation in the liver. Other 
adipocytokines that are important in NAFLD are resistin, leptin, visfatin, tumor necrosis factor 
alpha, and interleukin 6.  
. 
During the past decades, the scientific community have been working on a way to prevent the 
obesity associated  insulin resistance and NAFLD. The focus of this work is on possible cure, very 
trendy wich can be supplaide by the diet: omega 3 fatty acids. The observation that eschimo 
population (who have diet rich in fish, that contain omega3) show a lower risk of developing 
cardiovascular desease. The idea of beneficial effects of omega3  arised. 
In fact a lot of studies have demostrated that the increased intakes  of omega-3 marine fatty acids 
may improve defects in insulin signaling,  prevent alterations in glucose homeostasis and the further 
development of type 2 diabetes. This is largely mediated through a reduction in fatty acid 
accumulation in muscle and liver. N-3 Polyunsaturated fatty acids (n-3 PUFAs) reduce plasma 
triacylglycerols and improve the lipoprotein profile by decreasing the fraction of atherogenic small 
dense low density lipoprotein cholesterol. These effects are likely mediated through the activity of 
transcription factors relating to expression of genes involved in lipid oxidation and synthesis. Other 
pleiotrophic effects of omega-3 PUFAs may contribute to decrease the burden of the metabolic 
syndrome, such as modulating inflammation, platelet activation, endothelial function, and blood 
pressure.  
 
As previously reported the disfunction mitochondrial is associated with obesity. The role of PUFAs 
on mitochondria is no still clear. In my work of research I investigated the different effects of high 
fat diets rich in saturated fatty acids or polyunsaturated fatty acids on hepatic steatosis and insulin 
resistance in both liver and skeletal muscle. In particular evalueting if the beneficial effects of 
polyunsaturated fatty on hepatic steatosis and insulin resistance were associated with  mitochondrial 
in functionality changed.  
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During the third year of my phd, I focused on another possible target of omega 3 fatty acids, that 
could improve the insulin resistance. In fact, studies show that a HFD supplementd in o3 FA 
increases the expression of Apelin. 
Apelin is a bioactive peptide, associated with metabolic troubles and is known to have a role in both 
glucidic and lipidic metabolism. An increase in the plasma levels improves the insulin sensitivity. 
Omega3 fatty acid treatment increases this peptide‟s expression in cultured adipocytes, and in the 
adipose tissue of mice. Apelin is also expressed in other organs, among them are two major insulin 
sensitive organs: muscle and liver. 
The beneficial effects observed in the metabolism of animals supplemented with omega 3 fatty 
acids could be in part explained by an increase in apelin expression. 
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Chapter I 
ESSENTIAL FATTY ACIDS 
 
I. Generalities about FA 
 
The fatty acid is a carboxylic acid with a long unbranched aliphatic chain. Fatty acids generally 
have a chain with an even number of carbon atoms, from 4 to 28. Fatty acids are usually attached to 
triglycerides or phospholipids. When they are not, they are known as "free fatty acids” (FFA). Fatty 
acids are important sources of energy storage, and as they are metabolized, they yield large 
quantities of ATP. 
The fatty acid family is divided into three groups, which differ in the presence and number of 
double C=C bond in their aliphatic chain. 
 
classification of fatty acids 
 Saturated  fatty acids (SFA) have single bonds between all the carbon atoms. Most saturated 
fats are solid or semi solid at room temperature. Tey are the main component of animal-
derived fats, such as butter and lard. They are the main dietary culprit in raising blood 
cholesterol and in increasing the risk of coronary artery disease, type 2 diabetes, and 
obesity
7
.  
 
 Monounsatuated fatty acids (MUFA) have one double bond in the aliphatic chain. The 
MUFA content in our diet is mainly accounted for by oleic acid, the predominant 
component of olive oil. Monounsaturated oils are liquid at room temperature, but may 
become cloudy or semi solid at low temperature. They help to protect the cardiovascular 
system, they also reduce the risk of certain metabolic disorders such as insulin resistance 
and diabetes, and are linked with a lower rate of cancer
7
. 
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Polyunsaturated fatty acids (PUFA) are fatty acids that have two or more double bonds. PUFA 
consist of two families of fatty acids, omega-6 (ω-6) and omega-3(ω-3). The number following 
"Omega-" represents the position of the first double bond, counting from the terminal methyl group 
on the molecule. The ω-3 fatty acids have their first double bond between the 3rd and the 4th atom 
of carbon from the methyl end of the molecule, whereas in ω -6 fatty acids, the double bond is 
between the 6th and 7th atom of carbon(figure 1). 
Which  are called Essential Fatty Acids (EFA). Omega3 are abundant in fish, whereas the omega6 
is found in nuts. Concerning the heatlh effects, the PUFAs have the same protective actions than 
MUFAs. 
 
 
 
 
 
 
Fig 1 .Classification fatty acids: Saturated, Monounsaturated, Polyunsaturated and 
Essential fatty acids   
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II. ESSENTIAL FATTY ACIDS 
 
The essential fatty acids are the PUFAs that mammals are unable to synthesize: Eicosapentaenoic 
acid (EPA 20:5ω3) and DocosaHexaenoic acid (DHA 22:6ω3). In fact, is it necessary to introduce 
them with diet, directly or indirectly.  
 
Fish oil is naturally rich in EPA and DHA. These two EFA are also present in the marine mammals 
and phytoplankton, or obtained directly through oils from oily fish such as salmon, herring, 
mackerel, anchovies and sardines, or in cod liver oil but the major source is the cod liver oil. 
These fatty acids are especially enriched in the myocardium, retina, brain and sperm, and are 
essential for the proper functioning of these tissues and growth, being important modulators of 
many physiological processes 
8
. 
 
The precursor of ω-3 fatty acids synthesis is α-linolenic acid (ALA; 18:3 ω-3) whereas that of ω -6 
fatty acids is linoleic acid (LA; 18:2 ω -6). LA is found in the seeds of most plants with the 
exception of coconut, cocoa, and palm. ALA is found in the chloroplast of green leafy vegetables 
instead of the seeds, with the exception of flaxseed, and rapeseed oils. Walnuts are also rich in 
ALA
9
. 
 
The synthesis of EFAs requires the conversion of LA and ALA to longer chain metabolites. 
For the ω-3 fatty acids, ALA is converted into EPA and DHA. This implicates the elongation of the 
chain length and degree of unsaturation by adding extra double bonds to the fatty acid molecule. 
For the omaga6 fatty acids, LA is metabolized to arachidonic acid (AA; 20:4ω6),   
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1. synthesis of omega3 Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid 
(DHA) 
 
 The precursor of EPA is ALA.  It is converted into steridonic acid, by the delta6desaturase that 
adds a unsaturation. The aliphatic chain is then elongated into eicosatraenoic acid. By the action of 
deelta5desaturase, it is finally converted into EPA.  (figue 2) 
EPA is the precursor of the 3 series of prostaglandins (PGE 3) and the 5 series of leukotrienes  
(LTB5).  
About 6% to 21% of the ALA is converted to EPA.  
Docosahexaenoic Acid (DHA) is an omega-3 highly unsaturated fatty acid that is biosynthesized 
from eicosapentaenoic acid (EPA) by a further desaturation by delat4desaturase. (figure 2) 
 
2. synthesis of omega 6 
LA is converted to γ-linolenic acid (GLA, 18:3 ω-6) by the action of the enzyme delta- 6 desaturase 
(∆-6 desaturase). GLA is elongated to form dihomo-GLA (DGLA, 20:3 ω- 6), the precursor of the 1 
series of prostaglandins (PGs). DGLA can also be converted into arachidonic acid (AA, 20:4 ω-6) 
by the action of the ∆-5 desaturase.  
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Fig 2. Metabolic Pathways of Essential Fatty Acids 
 
 
EPA, DHA ans AA are used as precursors for eicosanoids. 
Eicosanoids are potent chemical messengers. They play critical roles in immune and inflammatory 
responses.  There are four families of eicosanoids, the prostaglandins, prostacyclins, the 
thromboxanes and the leukotrienes
17
 
9
. 
 For each, there are two or three separate series, derived either from an ω-3 or ω-6 EFA 
 The EPA-derived (omega3) ecosanoids have three double bonds, (e.g. PGG3, PGH3, PGI3, 
TXA3) while its leukotrienes have five, (LTB5). 
 The AA-derived (omega 6) ecosanoids have two double bonds, (e.g. PGG2, PGH2, PGI2, 
TXA2) while its leukotrienes have four, (LTB4). 
 
Two families of enzymes catalyze fatty acid oxygenation to produce the eicosanoids (figure 3): 
Cyclooxygenase, or COX, generates the prostanoids, while Lipoxygenase, or LOX, generates the 
leukotrienes. 
 
3. beneficial biological effects of PUFAS  
The beneficial health effects of omega-3 fatty acids, eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) were described first in the Greenland Eskimos who consumed a high 
seafood diet and had low rates of coronary heart disease, asthma, type 2 diabetes mellitus, and 
multiple sclerosis. Several sources of information suggest that Western diet contains excessive 
amounts of omega-6 polyunsaturated fatty acids (PUFA) and a very high omega-6/omega-3 
ratio,(15/1-16.7/1). This high ratio promotes the pathogenesis of many diseases, including 
cardiovascular diseases, cancers, and inflammatory and autoimmune diseases. Whereas increased 
levels of omega-3 PUFA (a lower omega-6/omega-3 ratio), exert suppressive effects.  
 
The long-chain ω-3 PUFA are major structural components of membrane phospholipids of tissues 
throughout the body and in addition, which have been shown to participate in numerous cellular 
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functions affecting membrane fluidity, membrane enzyme activities and eicosanoid synthesis
19
. Is 
known that the cell membrane fluidity is determined by its lipid composition. Increased 
incorporation of saturated fatty acids and cholesterol into the cell membranes render the membrane 
more rigid. ω-3  PUFAs reduce the presence of saturated fatty acids in membranes. 
 
Additional studies in animals showed that rats fed with fish oil supplementation had a reduction in 
fat accumulation associated with reduction in adipocyte hypertrophy
10
. Moreover, a decrease in 
adipocytes hypertrophy or hyperplasia prevents the accumulation of lipids in the liver and 
circulation
10
.  
Moreover data from animal studies show that the ω-3 fatty acids reduce insulin resistance, 
especially in liver and skeletal muscle. In fact, in liver, an increase in glycolysis and in glycogenesis 
is observed
11
.  
 
 Metabolic syndrome has usually been defined as the clustering of interrelated risk factors for 
cardiovascular disease and type 2 diabetes, including hyperglycemia, insulin resistance, 
hypertension, hypertriglyceridemia, obesity, decreased HDL-cholesterol
12
.  
Studies have shown that dietary modifications with an increase in ω-3 polyunsaturated fatty acids 
reduce one or more risk factors of metabolic syndrome
13
: they lower the elevated blood 
triacylglycerol concentrations
12
, and EPA also increases the levels of high-density lipoproteins 
14
 
and decreases LDL cholesterol, hence improving the cardiovascular status. (On the contrary ALA 
decreases the number of lipoprotein). 
Vascular defect is a manifestation of the dyslipidemia observed in the metabolic syndrome. The 
prostaglandin PGE2, dervider from EPA, is involved in the inhibition of plattelet aggregation and 
vasodilation, whereas TXA2   (derived from AA) is implicated in stimulation of platelet aggregation 
and vasoconstriction. 
        In the prevention of cardiovascular disease, a 4/1 ratio is associated with a 70% decrease in 
total mortality 
15
. The eicosanoids derived from omega 3 may play an important role in the 
prevention and treatment of coronary heart disease, hypertension, diabetes, arthritis, other 
inflammatory and auto-immune disorders
16
. 
 
Studies indicate that the optimal omega3/omega6 ratio is  2–3/1 suppresses inflammation in patients 
with rheumatoid arthritis 
17
.In addition the ω-3 fatty acids may also inihibit production of 
inflammatory mediators tumor necrosis factor-α (TNFα), interleukin (IL)18. In fact,  in vitro  studies 
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in macrophages treated with EPA and DHA show a reduction in the expression of TNF-α, IL6 and  
monocyte chemoattractant protein-1(MCP-1)
17
. This is interesting, because it is known that the 
obesity and metabolic syndrome are associated with a low grade inflammatory status, and that this 
inflammation is involved in the onset of obesity-associated pathologies, such as insulin resistance. 
Prostaglandins, thromboxanes and leukotrienes derived from the ω-6 have pro-inflammatory action, 
and are known to be involved in various pathological processes
19
 for example, LTB4 is involved in 
leukocyte chemotaxis. As the amounts of ω-6 fatty acids in the Western diet are high, they are 
formed in larger quantities than those formed from ω-3 fatty acids. 
 
The oxidative stress is involved in the pathologies of metabolic syndrome
20
. ω-3 fatty acids 
decrease the oxidative damages and restores free radical homeostasis. The mechanism involved in 
these effects is not completely understood, but evidences suggest that EPA and DHA increases the 
action of anti-oxidant enzymes
20
. 
 
This can explain that the changed in the western diet have associated with an increased of pathology 
associated with obesity 
 
 
Fig 3. Beneficial effect of omega 3 
 
 
III. omega 3 Regulation of Gene Expression 
PUFA are not only utilized as energy sources or fuel for the organism and structural components of 
cells, but also serve as important mediators of gene expression. 
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The results obtained in in vitro and in vivo studies indicate that ω-6 and ω-3 fatty acids can 
modulate the expression of a number of genes, including those involved with fatty acid metabolism 
and inflammation
21
. 
This part focuses on the regulation of gene expression involved in lipid metabolism. 
 
Among other mechanisms, PUFAs have been shown to exert their effects on gene transcription via 
nuclear receptors such as peroxisome proliferator-activated receptors (PPARs) and liver X receptors 
(LXRs), and through the transcription factor, sterol regulatory 
element binding protein (SREBP). 
 
PPARs 
n–3 fatty acids are important regulators of PPAR. There are at least 4 PPAR isoforms: alpha, beta, 
delta, and gamma, which have distinct, but interrelated functions. Activation of the PPAR 
superfamily is critical for controlling key proteins that are crucial for lipid homeostasis pathways. 
ω–3 Fatty acids have been reported to bind to at least PPARα and PPARγ wich produces 
physiological responses such as promoting ß-oxidation and adipogenesis. This action  on PPARs is 
mediated by the eicosanoid products of omega 3
22
. 
The possible mechanism of the gene regulation by the polyunsaturated fatty acids is explain in 
figure 4.  
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Fig.4 Mechanism of gene regulation by polyunsaturated fatty acids 
(please chloé make this with a mitochondria around the beta ox). Non esterified fatty acids (NEFA) 
are transported into the cell through membrane transporters(1), and are rapidly converted to acyl coenzyme A (CoA) by 
acyl CoA synthetase (ACS) (2). The acyl CoA can be oxidized (3) or can be esterified into complex lipids such as 
triglycerides (TG), phospholipids (PL), or diacylglycerols (DAG) (4). These complex lipids can also replenish the 
cellular fatty acid stores as necessary (5). Alternatively, fatty acyl CoAs can give rise to leukotrienes, prostaglandins, 
and thromboxanes (6). These secondary metabolites, in addition to complex lipids such as DAG, can increase cellular 
concentrations of second messengers such as cyclic AMP (cAMP), inositol triphosphate (IP3), and calcium (Ca) (7). 
These second messengers or their lipid precursors can all have effects on gene expression (8). Alternately, free fatty 
acids and fatty acyl CoAs can act directly at the nuclear level (9). In the nucleus, signaling through fatty acids or their 
metabolites can lead to changes in nuclear receptor activation (10), as in the case of peroxisome proliferator activated 
receptors and liver X receptors, or to changes in transcription factor abundance (11), as in the case of SREBP1c, leading 
to upregulation (12) or downregulation (13) of target genes. 
 
How explained in this chapter the omega 3 have the positive effects on health relate to 1) 
incorporation of n–3 fatty acids into membrane 2) inhibition or modulation of eicosanoid pathways, 
which leads to alteration of inflammatory responses and related protein expression and activity; and 
4) direct effects on gene expression.
 21
 In particular on the enzyme involved into beta-oxidation. The 
beta-oxidation is a mitochondrial process that is impared in insulin resistence and type2 diabetes.  
For this the omega 3 are a target for rescue of pathology associated at the obesity.  
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Chapter II 
ADIPOSE TISSUE 
 
I. Structure and function of adipose tissue 
Adipose tissue is a connective tissue consisting mainly of fat cells called adipocytes, specialized in 
the synthesis and storage of fat, mainly into triglycerides.   
. There are two types of adipose tissue: 
 white adipose tissue with adipocytes containing a large fat droplet, only a small amount of 
cytoplasm, and a flattened nucleus, localised in the periphery of the cell;  
  brown adipose tissue with adipocytes containing fat droplets of different sizes, a large 
amount of cytoplasm, a round and centrally located nucleus, and numerous mitochondria. 
 
 
 
 
 
Figure 6. White fat cell and brown fat cell. The single large lipid vacuole in the white fat cell and the 
numerous smaller lipid vacuoles in the brown fat cell. LV: lipid vacuole; M: mitochondria; N: nucleus. 
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These two types of adipose tissues are different in morphology and also in their function: 
White adipose tissue‟s first function is the storage of fat. This is allowed by enzymes specialised in 
the lipogenesis, and also by its capacity to increase its number (hyperplasia) and volume 
(hypertrophy) of mature adipocytes. 
This adipose tissue aalso acts as a fuel reserve and helps the conservation of the heat in the body. 
In times of significant energy expenditure (e.g., exercise) or lack of adequate energy intake (e.g., 
fasting), adipose cells release fatty acids, which can be used by muscles and other tissues as a 
source of energy. Enzymes contained in adipose cells are specialize in the hydrolysis of 
triglycerides in order to generate fatty acids and glycerol for physiological processes. 
 
Brown adipose tissue, which has a rich vascularization and densely packed mitochondria, is 
important for regulating body temperature via non-shivering thermogenesis, particularly in 
hibernating animals and neonates. 
This adipose tissue is different from the white adipose tissue, and this can be explained by the fact 
that they don‟t have the same embryonic origin. 
 In humans, the percentage of brown adipose found in the body decreases with age. In other 
animals, however, particularly those that hibernate (e.g., polar bears), it is found in adults and plays 
an important role in survival. They experience a drop in body temperature and a slowing of 
metabolism during winter dormancy, which allows them to conserve energy.  
This tissue is more effencient in terms of supplying energy, because there are mor mitochondria, 
and these mitochondria are richer in UnCoupling Proteins (UCP), which are implicated in the 
production of energy from fat. 
 
II. Adipose tissue as an endocrin organ  
 
The traditional view of adipose tissue as a simple passive reservoir for energy storage is no longer 
valid. As early as 1987, adipose tissue was identified as a major site for metabolism of sex steroids 
23 
and production of adipsin, an endocrine factor that is markedly down-regulated in rodent 
obesity
24
. The subsequent identification and characterization of leptin in 1994 firmly established 
adipose tissue as an endocrine organ 
25
. Adipose tissue is now known to express and secrete a 
variety of bioactive lipids, and also peptides, known as adipokines, which act at both the local 
(autocrine/paracrine) and systemic (endocrine) level. Some important adipokines will be described 
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in this chapter. In addition to these efferent signals, adipose tissue expresses numerous receptors 
that allow it to respond to afferent signals from traditional endocrine systems as well as the central 
nervous system (CNS). The importance of endocrine function of adipose tissue is emphasized by 
the adverse metabolic consequences of both adipose tissue excess or deficiency. The increase of 
adipose tissue, especially in the visceral compartment, is associated with insulin resistance, 
hyperglycemia, dyslipidemia, hypertension, and prothrombotic and proinflammatory states
26
. 
Interestingly, adipose tissue deficiency or lipodystrophy is also associated with features of the 
metabolic syndrome in both humans and rodents. Thus, both excess and deficiency of adipose tissue 
have harmful metabolic consequences. These disorders regulate the expression of the adipokines, 
which are implicated in their complications. 
 
 
Figure 7. Adipocyte secretory function. 
 
 
As previously described, the white adipose tissue secretes many adipokines, among which there is 
leptin, adiponectin,  TNFa, IL6 and Apelin (Figure 7). 
 
a. Leptin 
Leptin, the product of the obesity (ob) gene
27
, is a 16-kDa circulating hormone that is well known 
as a regulator of food intake and energy expenditure via hypothalamic- mediated effects
28
. This 
hormone has many additional effects, often as a consequence of direct peripheral actions. These 
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include angiogenesis, hematopoiesis, lipid and carbohydrate metabolism and effects on the 
reproductive, cardiovascular and immune systems
28
.  
Many of these effects, particularly on energy intake and expenditure, are mediated via hypothalamic 
pathways, whereas other effects are mediated via direct action on peripheral tissues including 
muscle and pancreatic β-cells29. 
 
Although initially viewed as an antiobesity hormone, leptin‟s primary role is to serve as a metabolic 
signal of energy sufficiency rather than excess
28
. But in contrast, common forms of obesity are 
characterized by elevated levels. This state has been termed “leptin resistance”. Several mechanisms 
may contribute to leptin resistance, one can be defects in leptin signaling or transport across the 
blood-brain barrier
29
. 
This hypothesis suggests that some cases of human obesity may be due to reduced leptin action in 
the brain. 
The effects of leptin on energy homeostasis are well documented
30 
with the spontaneous genetic 
obese and diabetic models of db/db, ob/ob mice, and Zucker fa/fa rats. 
 
Adipocytes are the major source of leptin synthesis and secretion, other sources include placenta, 
stomach and skeletal muscle
27
. Leptin expression is increased during obesity, by, insulin, TNF-a 
and glucocorticoids, and is negatively regulated by fasting, b-adrenergic agonists, free fatty acids, 
and Peroxysome Proliferator-activated receptor g agonist (PPARg)
31
. Leptin acts via 
transmembrane receptors (ob-R), which show structural similarity to those of the cytokine family
25, 
32
. 
 
The ob-R are produced in several alternatively spliced forms, designated ob-Ra, ob-Rb, ob-Rc, ob-
Rd, ob-Re and ob-Rf
25, 32, 33
, that have a common extracellular and transmembrane domain, and a 
variable intracellular domain, different for each of the isoforms.  
Leptin signaling occurs typically via Janus tyrosine kinases (JAKs) and Signal Transducers and 
Activators of Transcription (STATs). (Figure 8)  
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Figure 8 : Leptin intracellular signaling in the hypothalamus 
 
The JAK/STAT signalling pathway plays a critical role in mediating the effects of many cytokines 
and growth factors
45
. Leptin receptors don‟t have intrinsic tyrosine kinase activity, and many 
signalling events are dependent on association with kinases such as JAK2. JAKs are receptor-
associated protein tyrosine kinases, which are used to phosphorylate the receptor itself as well as 
targets such as STAT proteins.  
STATS are recruited and activated by obR/JAK complexes upon phosphorylation. The activated 
form of STATS constitute homo or heterodimers that translocate into the nucleus. It can then 
interact with specific DNA elements in the promoters of target genes to regulate gene expression
31 
like SOCS. 
b. Adiponectin 
  
Adiponectin is a 244-amino-acid-long polypeptide. There are four distinct regions in adiponectin : 
 the first is a short signal sequence that targets the hormone for secretion outside the cell;  
 the second  is a short region that varies between species; 
 the third is a 65-amino acid region with similarity to collagenous proteins;  
 the last is a globular domain. 
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Several oligomeric forms of native adiponectin circulating in the blood are described in the 
literature: trimers, hexamers, and higher order multimers. Trimers linked by disulfide bond form a 
hexamer (Figure 8). 
 
 
 
 
Fig.8 Schematic representation of adiponectin oligomeric forms 
 
Adiponectin binds to a number of receptors. So far, two receptors have been identified, with 
homology to G protein-coupled receptors
34
: 
 adiponectin receptor 1 – ADIPOR1 
 adiponectin receptor 2 – ADIPOR2 
 Expression of the receptors are correlated with insulin levels, as well as reduced in mouse 
models of diabetes, particularly in skeletal muscle and adipose tissue
34, 35
.
  
 
Adiponectin is exclusively secreted from adipose tissue into the bloodstream. It is a hormone that 
modulates a number of metabolic processes, including glucose regulation and fatty acid 
catabolism
34. 
Levels of the hormone are inversely correlated with body fat percentage in adults
36
. In 
fact, during obesity and diabetes, a decrease in circulating adiponectin is obesrved in both mice and 
humans. The same obervation as been reported in cardiovascular diseases, hypertension
37
, or 
metabolic syndrome
35
. Thus, reductions in plasma adiponectin levels are commonly related with 
insulin resistance state.(Figure 9) 
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Figure 9: Obesity, adiponectin resistance, and insulin resistance 
The  action of Adiponectin are : 
Reduction  tissue TG content and up-regulates insulin signaling.  
 
In skeletal muscle, adiponectin is involved in the expression of molecules implicated in fatty-acid 
transport and oxidation such as AcylCoenzymeA oxidase, and in energy dissipation such as UCP2. 
Increased tissue TG content in obesity has been reported to interfere with insulin-stimulated 
phosphatidylinositol (PI) 3-kinase activation and subsequent glucose transporter 4 translocation and 
glucose uptake, leading to insulin resistance
38
. Mice treated with adiponectin showed a decreased 
tissue TG content in muscle. This may contribute to improved insulin signal transduction, 
associated with increases in insulin-induced tyrosine phosphorylation of insulin receptor and IRS- 1 
and Akt
39
. 
Activation of PPARα. 
 
 Based on the data that treatment of lipoatrophic or obese diabetic mice with adiponectin or 
overexpression of adiponectin in ob/ob mice resulted in increased expression levels of PPARα. 
Consistent with this hypothesis, adiponectin indeed increased the expression levels of PPARα in the 
animal
61
. These data suggested that adiponectin increased fatty-acid oxidation  and energy 
consumption, presumably via PPARα activation at least in part, which led to decreased TG and 
DAG content in the liver and skeletal muscle and thus coordinately increased in vivo insulin 
sensitivity
40
. 
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Activation of  AMP activated kinase.  
 
AMPK is an enzyme involved in the cell energy balance.  It is a heterotrimere, with a,b and ,g 
subunits. 
Its is an „energy sensor‟, as it is activated when the intracellular AMP/ATP ratio is too high. AMP 
binds to its alpha-subunit, which is the catalytic subunit, whereas the b and g subunits are 
regulatory. The AMPK then activates by phosphorylation downstream actors involved in metabolic 
pathways. 
 
The activation of AMPK by adiponectin has been shown by experiments in vitro and in vivo: The 
stimulation of glucose utilization and fatty-acid oxidation by adiponectin occurs through activation 
of AMPK
41, 42
. 
c.  TNFα 
 
TNFα is a pro-inflammatory cytokine. TNFα is a 26-kDa transmembrane protein that is cleaved into 
a 17-kDa biologically active protein that exerts its effects via type I and type II TNFα receptors. 
The receptor TNF-R1 is expressed in most tissues, and can be activated by both the membrane-
bound and soluble trimeric forms of TNF, whereas TNF-R2 is found only in cells of the immune 
system, and respond to the membrane-bound form of the TNF homotrimer. 
Within adipose tissue, TNFα is expressed by stromavascular cells43 and adipocytes. As such, it is 
now considered as an adipokine. 
Upon contact with their ligand, TNF receptors also form trimers. This binding causes a 
conformational change in the receptor, leading to the dissociation of an inhibitory protein from the 
intracellular death domain of the receptor. This dissociation enables the adaptor protein TRADD to 
bind to this death domain, serving as a platform for subsequent protein binding. Following TRADD 
binding, three pathways can be initiated
43, 44
 :  
Activation of NF-κB, Activation of the MAPK pathways, and Induction of death signaling, as 
explained in figure 10. 
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Fig.10 Signaling pathway of TNF-R1 
Activation of NF-κB 
TRADD recruits TRAF2 and RIP. TRAF2 then triggers a phosphorylation cascade resulting in the 
activation of NF-κB. NF-κB is a heterodimeric transcription factor that translocates into the nucleus 
and mediates the transcription of a vast array of proteins involved in cell survival and proliferation, 
inflammatory response, and anti-apoptotic factors. 
Activation of the MAPK pathways 
In this patway TNFa  induces a activation of the stress-related JNK group by a  phosphorylation 
cascade JNK translocates to the nucleus and activates transcription factors implicated in cell 
differentiation, proliferation, and is generally pro-apoptotic.  
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Induction of death signaling  
In this patway TRADD binds FADD, which then recruits the cysteine protease caspase-8. A high 
concentration of caspase-8 induces its autoproteolytic activation and subsequent cleaving of effector 
caspases, leading to cell apoptosis. 
 
TNFα is increased in obese rodents and humans and is positively correlated with adiposity and 
insulin resistance
45, 46
. Moreover TNFα influences gene expression in metabolically important 
tissues such as liver and adipose tissue.   
 
In liver, TNFα suppresses expression of genes involved in glucose uptake and metabolism and fatty 
acid oxidation and increases expression of genes involved in de novo synthesis of cholesterol and 
fatty acids and, at the same time, reduces the expression of genes involved in glucose uptake and 
metabolism and FA oxidation
43
. 
 
In adipose tissue, TNFα represses genes involved in uptake and storage of NEFAs and glucose, 
suppresses genes for transcription factors involved in adipogenesis and lipogenesis, and changes 
expression of several adipocyte secreted factors including adiponectin and IL-6, apelin 
47
. 
 
The mechanisms implicated in the insulin resistance can be: 
 Implication of JNK mediated insulin receptor substrate (IRS)-1phosphorylation at serine, 
which inhibits normal tyrosine phosphorylation of IRS-1 and consequently reduces the 
activation of the insulin signaling cascade. 
 A second mechanism whereby TNF-α may contribute to insulin resistance is through 
elevations in circulating FFA levels caused by the induction of lipolysis and stimulation of 
hepatic lipogenesis.  
d. Interleukin-6 (IL-6) 
 
Adipose tissue IL-6 expression and circulating IL-6 concentrations are positively correlated with 
obesity, impaired glucose tolerance, and insulin resistance
48
.  
Plasma IL-6 concentrations predict the development of type 2 diabetes and cardiovascular disease
49
. 
Major IL-6 concentration has been estimated to originate from adipose tissue
48
. 
Besides inflammatory stimuli and stress, hormones appear to have an effect on IL-6 production. 
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Role of IL-6  in metabolism: 
 Glucose metabolism 
Experiments have demonstrated that IL-6 can reduce insulin-dependent hepatic glycogen 
synthesis
50, 51 
and glucose uptake in adipocytes. Moreover in rodents, IL-6 injections lead to 
increased plasma glucose and insulin levels and a marked decrease in liver glycogen after 90 
minutes. The intricate mechanism of cytokine-induced insulin resistance has not been clearly 
defined, but there are several hypotheses. One possible mechanism is the serine phosphorylation of 
insulin receptor substrate 1 (IRS-1) by cytokine-activated kinases and the subsequent direct 
inhibitory effect on the insulin-signaling cascade
52
. 
Lipid metabolism 
On the other hand, IL-6 has been shown to inhibit lipoprotein lipase and stimulate lipolysis. 
This lipolytic property of IL-6 may indirectly induce insulin resistance
51
. An alternative mechanism 
may be the cytokine-induced expression of cellular proteins, such as members of the suppressor-of-
cytokine-signaling (SOCS) family, which inhibit insulin receptor signal transduction
53
. 
 
I will now focus on apelin since I have been working on this adipokine during the last year of my 
thesis. 
e. APELIN 
Apelin is a novel bioactive peptide identified as the endogenous ligand of the orphan G protein 
coupled receptor, APJ
54
.  
The apelin gene encodes a 77 amino acid preproproapelin that is cleaved on hydrophobic aminoacid 
wich site to shorter biologically active peptides, including apelin-36, apelin-17, apelin-13 and 
apelin-12. All this formhavr in common the C teminal extremity. In laboratory apelin 13 
pyroglutamined form is often us. This is a peptide with a pyroglutamate substitution at the N 
terminus, a common post-translational modification that preserves biological activity by rendering 
the peptide more resistant to enzymatic cleavage. This form exist in vivo. Apelin is widely 
expressed. The study of O‟Dowaod in 2000 allows to describe apelin expression in organs in 
human. Apelin is manly expressed in brain (hypothalamus), lung, mammary gland, heart and 
adipose tissue.  
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Figure  Apelin  
 
The APJ receptor is a G-protein-coupled receptor (GPCR) identified in 1993 by homology cloning 
and designated an „orphan‟ until 1998 when its endogenous ligand was identified as apelin. It is also 
expressed in different tissues. The affinity between APJ and apelin is different with the Apelin 
form. Since this pairing, a number of roles for the apelin/APJ system have emerged including the 
cardiovascular system (chronotrop, inotrop positiv abd vasodilatator effects), regulation of hydric 
balance (decrease of AVP secretion), angiogenesis and adipose tissu that wr will better describe
55
. 
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Chapter III 
 INSULIN RESISTANCE 
 
Insulin resistance is a pathological status in which target tissues of insulin, such as liver, adipose 
tissue and skeletal muscles, don‟t respond properly to this hormone. It is the status that precedes 
type 2 diabetes, and obesity is the main risk factor for the development of insulin resistance. 
Besides, obesity and insulin resistance are positively correlated
56
. 
I. Insulin  
1. Structure of Insulin 
Insulin is a 51 amino acids hormone. It contains two polypeptide chains linked by two disulfide 
bonds connecting chain A with chain B. There is also a third disulfide bond on the chain A. Chain 
A consists of 21 amino acids and the chain B contains 30 amino acids. Insulin is originally 
produced as preproinsulin, which is transformed into the pro-insulin by proteolytic action, and 
finally into the active polypeptide hormone, insulin. 
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Figure X The amino acid diagram of human insulin, showing the A and B chains and the 3 disulfide 
bonds 
 
 
Figure  Converting preproinsulin into insulin. 
                 
2. Insulin secretion  
 
Insulin is synthesized in the -cells of the Langerhans islets in the pancreas. The main function of 
the endocrine pancreas is to produce and secrete insulin and other hormones, and the main function 
of the exocrine pancreas is the excretion of digestive enzymes. The secretion of insulin is 
controlled by the glucose concentrations in the blood stream: as the level of glucose rises in the 
blood, the pancresas secretes insulin.  
As glucose enters into the -cell through the GLUT2 transporters, it is metabolized into ATP, and 
the elevation of the ATP/ADP ratio induces the closure of the cell-surface ATP-sensitive K
+
 
channels, leading to the membrane depolarization. Cell-surface voltage-dependant Ca
2+
 channels 
are opened, facilitating the extracellular calcium to rush into the cell. A rise in free cytosolic Ca
2+
 
triggers the exocytosis of insulin vesicles. 
 
 
 
Figure 5. Diagram of the insulin and glucose regulation model. As blood glucose rises, insulin is 
secreted in the pancreas, circulates throughout the body, glucose is taken up by cells and blood sugar 
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decreases. With a decrease in blood sugar, the pancreas secretes glucagon to breakdown glycogen in the 
liver and release glucose into the blood.  
 
 
 
3. Insulin receptors  
Most cells throughout the human body possess insulin receptors on their membrane. 
The insulin receptors are tyrosine kinase, integral membrane proteins, which contain two α-
subunits and two -subunits. The α-subunits are entirely extracellular and hold the binding site for 
the insulin. The -subunits are attached to each of the α-subunits by a sulfur bonds and extend 
through the plasma membrane to anchor the receptor in the cell wall. The two α/-complexes are 
connected by a disulfide bond to form the hetereotetramere. 
  
  
Figure 6. An insulin receptor. This insulin receptor has two α subunits (yellow) and two  subunits (blue). 
The red lines are bonds, showing the sulfur bond between the α and  subunits and a disulfide bond 
between the two complexes .  
4. The insulin pathway 
Binding of insulin to the α-subunit induces a conformational change resulting in the 
autophosphorylation of a number of tyrosine residues present in the β-subunit 57. These 
phosphorylated residues are recognised by phosphotyrosine-binding (PTB) domains of adaptor 
proteins such as members of the insulin receptor substrate family (IRS)
58
. Receptor activation leads 
to the phosphorylation of IRS proteins, some of which are recognised by the Src homology 2 (SH2) 
domain of the p85 regulatory subunit of PI 3-kinase. The catalytic subunit of PI 3-kinase, p110, 
then phosphorylates phosphatidylinositol (4,5) bisphosphate (PtdIns(4,5)P2) leading to the 
formation of Ptd(3,4,5)P3.  
This pathway leads to the GLUT 4 translocation and to the regulation of gene expression, as shown 
in picture X. 
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Figure7. Insulin pathway  
 
A key downstream effector of Ptd (3,4,5)P3 is Akt (also known as PKB), which is recruited to the 
plasma membrane. Akt promotes the translocation of GLUT-4 vesicles from their intracellular pool 
to the plasma membrane, where they uptake the glucose into the cell. 
Other signal transduction proteins interact with IRS molecules, including GRB2 and SHP2, a 
protein-tyrosine phosphatase (PTP) containing SH2 domains. GRB2, an adaptor protein, contains 
an SH3 domain, which allows constitutive association with the guanine nucleotide exchange factor 
mSOS and is part of the cascade including RAS, RAF and MEK that leads to activation of mitogen-
activated protein kinase (MAPK) and mitogenic responses in the form of gene transcription 
stimulated by FOS and ELK1, like hexokinase, GLUT transporters, SOCS3… 
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5. Physiological Effects of Insulin 
Insulin regulates the metabolism by acting on the numerous insulin-sensitive tissues, such as 
skeletal muscles, liver and adipose tissue. It exerts it action on the carbohydrate and lipid 
metabolism. 
 
f. Insulin and Carbohydrate Metabolism 
 
Glucose metabolism is regulated by insulin in different types of cells.  
Two important effects are:  
Insulin facilitates entry of glucose into muscle and, adipose tissue 
Once insulin binds to the insulin receptors, cytoplasmic vesicles containing GLUT-4 (glucose 
transporters) fuse with the plasma membrane. GLUT-4 is one isoform of the 12 members od the 
GLUT transporters family. It is expressed in skeletal musce and AT, and it‟s the only one of the 
GLUT family whose translocation in the plasma membrane is under the control of insulin.When 
blood levels of insulin decrease, insulin receptors are no longer occupied, and the glucose 
transporters are recycled back into the cytoplasm 
59
.  
 
 
  Fig 8 Mechanism of glucose transport  
 
  
36 
 
Insulin stimulates the storage of glucose in the liver.  
Insulin has several effects in liver which stimulate glycogen synthesis. First, it activates the 
hexokinase, which phosphorylates glucose, trapping it within the cell. Coincidently, insulin acts to 
inhibit the activity of glucose-6-phosphatase. Insulin also activates several of the enzymes that are 
directly involved in glycogen synthesis, including phosphofructokinase and glycogen synthase. 
Insulin also has an inhibitory effect on the hepatic glucose produvtion (neoglucogenesis) 
 
 
 
 
Fig 9 Synthesis of glycogen  
 
g. Insulin and Lipid Metabolism 
Insulin also has important effects on lipid metabolism. This effect of insulin on lipid metabolism 
include the following:  
Insulin promotes synthesis of fatty acids in the liver  
As discussed above, insulin is stimulatory to synthesis of glycogen in the liver.  
When the liver is saturated with glycogen, any additional glucose taken up by hepatocytes is 
shunted into pathways leading to synthesis of fatty acids (lipogenesis de novo), which are exported 
from the liver as lipoproteins. The lipoproteins are ripped apart in the circulation, providing free 
fatty acids for use in other tissues, including adipocytes, which use them to synthesize triglyceride. 
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Insulin promotes the lipogenesis I adipose tissue 
Insulin also facilitates entry of glucose into adipocytes, and within those cells, glucose can be used 
to synthesize glycerol. This glycerol, along with the free fatty acids delivered from the liver, is 
used to synthesize triglyceride within the adipocyte. By these mechanisms, insulin is involved in 
further accumulation of triglyceride in fat cells.  
Insulin inhibits lipolysis in adipose tissue  
Insulin is the only anti-lipolytic hormone, and exerts this action by inhibiting beta-agonists of 
lipolysis. 
 
 
 
 
 
 
 
6. Insulin resistance 
Basically, insulin resistance is defined by: 
An increase in the hepatic production of glucose, a decrease in glucose transport in muscle and 
adipose tissue, and an excessive lipolysis with a resulting  increase in plasmatic free fatty acids 
levels. The resultant of these defects is a high fasting glycemia, which is compensated by an 
increase in insulinemia in the first stages, to maintain a normal glycemia. At one point, the 
hyperinsulinemia can‟t counteract the insulin resistance anymore, both the insulin and glucose 
levels are high, and this is the characteristic of a type 2 diabetes. 
 
The development of insulin resistance is not the consequence of one unique defect. It is a 
combination of different alteration which can appear in every steps of the insulin sigballisation 
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pathway. In this part, different defect will be described from the receptor to the transcriptional 
control of genes, among which are free fatty acids. 
h. Imoprtant role of Ser/Thr phosphorylations 
The phospohorylation on the Ser/thr residues seems to have an antagonist role in receptor and IRS 
proteins, about the Tyr residues phosphorylation. This last phosphorylation are necessary to the 
normal signaling pathway of insulin.Studies describe the SR/thr phsopr° on irs1 and irs2 prots 
which uncouples them from the receptor and stops the insulin signal transduction (with a 
conformational change, or a subcellular relocalization of irs1). Different signals can induce this 
phosphorylation, as diacylglycerol (DAG), acyl-coA, glucose, or insulin itself. Other adipocyte 
secretions such as ffa or adipokines can also be involved in this inhibitory phosphorylation. Among 
this enzymes able to phosphorylate the ser/thr  of IRS, are IKKb kinase (inhibitor of nuclear factor 
Kb kinase NFKB), MAPK, JUNK and PKC proteins. 
One major regulation is the excess of intracellulair DAG, which activate the C1 domain of the PKC 
family members. Classic PKCs become activated when calcium binds to the C2 domain, increasing 
the affinity of the C1 domain for DAG. The potential role of PKCs in regulating insulin action has 
long been recognized: in rodents, a high-fat diet increases the concentration of intracellular DAG. 
The importance of activation of PKCs and serine phosphorylation of IRS1 for the development of 
insulin resistance was shown in mice without PKC.  
i. Muscle specific disregulation in GLUT 4  TRASLOCATION  
In physiological condition, when phosphorylated, IRS1 activates 1-phosphatidylinositol 3-kinase 
(PI3K). This enzyme, through signalling intermediates, activates Akt2, which phosphorylates and 
inactivates AS160, a protein that prevents translocation of GLUT4 through its interaction with Rab 
proteins. The tyrosine phosphorylation of IRS1 and associated activation of PI3K are impaired in 
rodent models of insulin resistance. Similarly, IRS1-associated PI3K activity is greatly reduced in 
the muscles of individuals being given lipid infusions, indicating that the lipid-induced reduction in 
insulin-stimulated glucose transport was attributable to a defect in insulin signalling
39
.  
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Figure 7 Mechanisms of insulin sensitivity and resistance in muscle  
 
The reduced trasmlocation of GLUT 4 in the membrane is the result of the many causes. One of these is 
the accumulation of DAG in the cell.  
j. Mechanisms of hepatic insulin resistance: possible link with steatosis 
Insulin signalization  in the liver has many similarities with insulin signalization in muscle. In the 
liver, insulin activates the insulin receptor kinase, which phosphorylates IRS1 and IRS2, leading to 
activation of PI3K and ultimately Akt2 (Figure) At this point, Akt2 activation promotes glycogen 
synthesis and inhibits gluconeogenesis.  
Furthermore, insulin-resistant individuals had a large increase in liver triglyceride content, 
attributable to a roughly two-fold increase in hepatic de-novo lipogenesis. This ectopic lipid 
accumulation in the liver, called stéatosés, is now widely known as non-alcoholic fatty liver disease. 
Steatosis is closely associated with obesity, insulin resistance, and type 2 diabetes mellitus.  
Many investigators have suggested that non-alcoholic fatty liver disease develops in the setting of 
insulin resistance..  
In the physiological condition, insulin signal transduction activates Akt, which inhibits the 
expression of FOXO1 and FOXA2 genes, involved in the neoglugogenesis on one hand, and 
stimulates the glucose storage by inhibiting GSK3 (Glycogen synthase kinase3). 
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In the liver, as in muscle, the accumulation of DAG induce the activation of PKC, which inhibits 
IRS docking on the insulin receptor
60
. The activation of Akt is then prevented which leads to an 
increase in the hepatic glucose production and a decrease in its storage 
 
 
 
Fig. 8 Mechanisms of insulin sensitivity and resistance in liver 
 
 
 
k. Inflammation, endoplasmic-reticulum stress and insulin resistance 
 
Clinically, insulin resistance and a proinflammatory state are both associated with the metabolic 
syndrome. Mechanistically, inflammatory signals affect cellular pathways that intersect with insulin 
action. Specifically, inflammatory signals such as TNFa and IL6 activate serine and threonine 
kinases such as Iκ kinase β and jun-N terminal kinase. Inflammatory pathways might also be 
activated in response to endoplasmic-reticulum stress. Modulation of endoplasmicreticulum stress 
by genetic or chemical means ameliorates jun-N terminal kinase activation and the development of 
insulin resistance. Substantial weight loss in patients after bariatric surgery has also been associated 
with both improvements in insulin sensitivity and reduction in markers of endoplasmic-reticulum 
stress.  
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The three first paragraphs, fatty acids, adipose tissue secrections and insulin resistence are 
clearly  linked 
- FFA are responsible for the lipotox effect. In obesity FFA in increased in plasma, and are 
ectopically stored, for example in muscle and liver. This increase is associated with an 
increase of DAG, leading to an increase of activated PKC
61
. This increases the IRS1 
phosphorylation on SER, which decreases its activation by Insulin receptor. Mice invalidates 
for PKCteta are protected against defects in glucose transport induced by a lipid infusion
62
  
It is important to keep in mind that all lipid species are not deleterious for the insulin 
signaling. For example, omega3 FA has many beneficial effects; They promote hepatic fatty 
acid oidation through PPARa-depentdant mechanism. 
- Adipose tissue secretion, the adipok, are regulated with obesity and can act with benefic or 
deleterious effecs on insulin sensitivity. Here is a non exhaustive list of these adipokines:  
o TNFa, IL6, resistin, MCP1 are deleterious 
o Leptin, adiponectin, chemerin, apelin are beneficial 
The expression of adipokines is regulated by numerous parameters. Omage3 FA activate 
the PPARg transcription factor which increase the expression of Adiponectin, thereby 
preventing ectopic DAG accumulation, and preserving insulin action, despite HFD. 
Another factor that can modulate IR is the mitochondrial defect that will be developed in the next 
part. 
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Chapter 4 
Mitochondrion 
 
During obesity and insulin resistance, different tissues develop functional modifications such as 
plasticity of adipocytes, inflammation, fibrosis, or endoplasmic reticulum stress. One other is the 
oxidative stress which appears in mitochondria.  
I. Structure 
Mitochondrion is an organelle present in cytoplasm of the most eukaryotic cells. It is considered as 
the power supply of the cell as it generates most of the adenosine triphosphate (ATP), which is used 
as a source of chemical energy within in the cells. In addition to supplying cellular energy, 
mitochondria are involved in a range of other cellular processes, such as differentiation, death and 
growth. 
Interestingly, mitochondrion contains proteins encoded by both nucleus genome and by its own 
genome.  
This organelle is composed of compartments that carry out specialized functions. These 
compartments include the outer membrane, the intermembrane space, the inner membrane, and the 
cristae (formed by infoldings of the inner membrane) and matrix. 
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1. The outer membrane 
The outer mitochondrial membrane encloses the organelle. It is characterized by numerous integral 
proteins called porins, which contain an internal channel (about 2-3 nm) that is permeable to all 
molecules of 5000 daltons or less. Larger molecules can only cross the outer membrane using active 
transport through mitochondrial membrane transport proteins. The outer membrane also contains 
enzymes involved in diverse activities as the elongation of fatty acids. 
The mitochondrial outer membrane can associate with the endoplasmic reticulum (ER) membrane, 
in a structure called MAM (mitochondria-associated ER membrane). This is important in ER-
mitochondria calcium signaling and is also involved in the transfer of lipids between the ER and 
mitochondria. 
2. The intermembrane space 
The intermembrane space is the space between the outer membrane and the inner membrane. 
Because the outer membrane is freely permeable to small molecules, the concentrations of these 
molecules, such as ions and sugars, in the intermembrane space is the same as the cytosol. 
However, large proteins must have a specific signaling sequence to be transported across the outer 
membrane 
 
3. The inner membrane 
 
The mitochondrial inner membrane is characterized by numerous infoldings that increase the 
membrane surface. It contains specific proteins giving to mitochondria their major function: 
 Redox reactions of oxidative phosphorylation 
 Generation of ATP  
 Mitochondrial fusion and fission  
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4. The matrix 
 
The matrix is the space enclosed by the inner membrane. The matrix contains the enzyme involved 
in the terminal oxidation of metabolic substrates. Indeed, it contains the enzyme of β-oxidation and 
Krebs cycle. These metabolic pathways are closely associated with the electron chain transport and 
the production of ATP through ATP synthase contained in the inner membrane. 
 
II. Production of energy in mitochondrion 
Basically, lipid and carbohydrates are oxidized in mitochondrial matrix through Krebs cycle. This 
enzymatic cycle induces the production of reduced coenzymes NADH and FADH2. Mitochondria 
use high energy containing-electrons of these reduced coenzymes to induce a transfer of protons 
across the inner membrane, modifying this electrochemical gradient which allows the activation of 
ATP synthase and the production of ATP. 
1. Mitochondrial oxidation 
Carbohydrates are first degradated within the cytosol though the glycolytic pathway. Glycolys 
produces pyruvate from glucose, which can enter the mitochondrion. In the matrix, pyruvate 
deshydrogenase complexe (PDC) catalyzed its degradation in acetyl-CoA and reduced coenzymes 
NADH. 
Lipids are transported within the matrix of mitochondrion and are degradated in acetyl-CoA in a 
metabolic pathway called β-oxidation. As for PDC activity, this degradation is associated with the 
production of both NADH and FADH2. 
Acetyl-CoA from glucose or lipid metabolism in the matrix can enter Krebs cycle. In this cycle, 
acetyl-CoA is transformed in CO2. This final oxidation is associated with an abundant production 
of reduced equivalents (3 NADH and 1 FADH2 produced for each acetyl-CoA cycle). 
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2. The electron transport chain of the inner membrane 
There are four complexes involved in the mitochondrial electron transport, usually called 
complexes I to IV. Electron transfer between these complexes is accomplished by the mobile 
coenzymes ubiquinone and cytochrome c.  
 
 
Complex I accepts electrons of NADH coenzyme arising from PDC, β-oxidation and Krebs cycle. 
Within this complex, NDH transfers its electrons to the mitochondrial chain. Part of the energy of 
these electrons is used to pump actively protons across the inner membrane. Electrons are then 
transferred to complex III via coenzyme Q.  
Complex II accepts electrons from FADH2 arising from β-oxidation and Krebs cycle. Complex II 
regenerates FAD that can be reused by the oxidation processes. Electrons from FADH2 are 
transferred to complex III via coenzyme Q.  
Complex III uses another part of the energy of the electrons to pump additional protons across the 
inner mitochondrial membrane. The electrons are then transported to complex IV via cytochrome c, 
where the remaining energy is used to pump protons across the membrane. 
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The de-energized electrons are then transferred to oxygen, the final electron acceptor in complex 
IV, to generate water. 
The relative excess of protons, generated by the active pumping of complex I,III and IV of the 
electron transfer chain, in the intermembrane space creates a pH and redox gradient across the inner 
mitochondrial membrane. The energy of this gradient, which is known as the proton motive force, is 
used by ATP synthase to convert adenosine diphosphate (ADP) to adenosine triphosphate (ATP). 
Indeed, the return of the excessive protons in the matrix through the channel of ATP synthase is 
associated with a synthesis of ATP. 
However, some protons return to the matrix through alternative leak pathways, causing mild 
uncoupling and lowering the efficiency of ATP production. This creates a futile cycle of pump and 
leak of protons across the mitochondrial inner membrane. 
At least two types of mitochondrial carrier cause significant inhibitor-sensitive inducible proton 
conductance when they are activated. The first type is the UCPs (uncoupling proteins), which cause 
nucleotide-sensitive proton leak when they are activated by fatty acids. The second type is the ANT 
(adenine nucleotide translocase), which exchanges ADP for ATP across the mitochondrial inner 
membrane and may also play an important role in the mitochondrial permeability transition pore 
and the mitochondrial apoptosis pathway. 
For these systems, there is a striking correlation between mitochondrial proton conductance and the 
fatty acyl composition of inner membrane phospholipids. In fact, the content of n-3 
polyunsaturated, in particular docosahexaenoate, correlates with high proton conductance, and the 
content of monounsaturated fatty acids, particularly oleate, correlates with low proton conductance.  
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III. Mitochondrial fusion and fission 
 
The mitochondria are dynamic organelles that undergo continual cycles of fusion and fission, which 
play an important role in the regulation of apoptosis. The equilibrium of these two processes 
determines not only the overall morphology of mitochondria within the cells, but also has important 
consequences for the number of mitochondria in the cytoplasm.  
1. Mitochondrial fusion 
Mitochondrial fusion is a mechanistically complex event as it involves the fusion of two lipid 
membranes (the inner and outer mitochondrial membranes). This process is dependent on both 
mitochondrial membrane potential and GTP
63, 64
 and. Furthermore, it is a two-step process, where 
the outer and inner mitochondrial membranes fuse in separable steps
65
. Importantly, the pro-fusion 
protein located in the inner mitochondrial membrane (optic atrophy gene 1 or OPA1) and the pro-
fusion proteins located in the outer membrane (mitofusins or Mfn) are detected in the same 
complex
66
, thereby suggesting that the two steps are co-regulated or coordinated. Indeed, the single 
disruption of Mfn or OPA1 is sufficient to stop the mitochondrial fusion process
67, 68
. 
The proteins identified to date that directly mediate mammalian mitochondrial fusion are the 
aforementioned mitofusins (mitofusin 1/Mfn1 and mitofusin 2/Mfn2) and OPA1. They are 
dynamin-related proteins, anchored in the mitochondrial membranes, and show GTPase activity, 
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which is essential for their mitochondria-fusing activity. Despite these similarities, OPA1 has many 
specific features in its regulation that are not shared with Mfns. 
2. Mitochondrial fission 
The most relevant genes identified to date that directly mediate mitochondrial fission are 
Drp1/Dnm1l (Dynamin-related protein 1/Dynamin 1-like gene) and Fis1 (Fission 1 homologous 
protein). Drp1 is a soluble dynamin-related GTPase located in the cytosol, as it does not contain any 
transmembrane domain
69
. This observation implies that in order to localize in the outer 
mitochondrial membrane to mediate mitochondrial fission, Drp1 must bind to a protein anchored in 
the outer mitochondrial membrane. This protein has been showed to be Fis1
70
. 
Fis1 is a small protein of 17 kDa anchored in the outer mitochondrial membrane and it does not 
contain domains with any known enzymatic activity. It contains six alpha helices and a 
transmembrane domain. Four of these helices encompass two TPR (tetratricopeptide repeat) motifs 
that are involved in protein–protein interactions. This observation suggests that Fis1 fission activity 
is mediated through its binding to Drp1 or to other mitochondrial fission proteins that remain to be 
determined. 
Since the first study that demonstrated an increase in mitochondrial fission in apoptosis and that a 
specific decrease in mitochondrial fission rates reduces sensitivity to apoptosis, Drp1 and Fis1 have 
been studied mostly in the context of programmed cell death. 
Several lines of experimental evidence support a role of mitochondrial dynamics in mitochondrial 
function and cellular metabolism. 
 
IV. Mitochondrial dysfunction and insulin resistance  
 
It is well established that mitochondrial function is required for normal glucose-stimulated insulin 
secretion from pancreatic β cells. In addition, maternally inherited defects in mitochondrial DNA 
that disrupt mitochondrial function are known to cause an insulin-deficient form of diabetes 
resembling type 1 diabetes. These changes were accompanied by decreases in both mitochondrial 
oxidative activity and mitochondrial ATP synthesis. 
These data support the hypothesis that insulin resistance arises from defects in mitochondrial fatty 
acid oxidation, which in turn lead to an increase in intracellular fatty acid metabolites that disrupt 
insulin signaling (Fig. 8). 
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Fig. 8 Potential mechanism by which mitochondrial dysfunction induces insulin resistance in skeletal muscle.  
 
 
It was well described in muscle that a decrease in mitochondrial fatty acid oxidation, caused by 
mitochondrial dysfunction and/or reduced mitochondrial content, produces increased levels of 
intracellular fatty acyl-CoA and diacylglycerol. These molecules activate novel protein kinase C, 
which in turn activates a serine kinase cascade (possibly involving inhibitor of nuclear factor kB 
kinase (IKK) and c-Jun N-terminal kinase–1), leading to increased serine phosphorylation of insulin 
receptor substrate–1 (IRS-1). Increased serine phosphorylation of IRS-1 on critical sites (e.g., IRS-1 
Ser307) blocks IRS-1 tyrosine phosphorylation by the insulin receptor and then inhibits the activity 
of phosphatidyl inositol 3-kinase (PI 3-kinase). This inhibition results in suppression of insulin-
stimulated glucose transport, the process by which glucose is removed from the blood.  
 
Another mitochondrial dysfunction implicated in insulin resistance is the oxidative stress. The 
mitochondrial respiratory chain is a major source of reactive oxygen species (ROS) which are 
chemically reactive molecules containing oxygen. Under normal circumstances, cells are able to 
defend themselves against ROS damage with enzymes such as superoxide dismutases, catalases, 
lactoperoxidases, glutathione peroxidases and peroxiredoxins. Small antioxidative molecule such as 
ascorbic acid (vitamin C), tocopherol (vitamin E), uric acid, and glutathione also play important 
roles as cellular antioxidants.  
Even though ROS can permit signaling when there are transitory produced, they are known to have 
deleterious effects
71
. 
The harmful effects of reactive oxygen species on the cell are most often: 
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1. damage of DNA 
2. oxidations of polyunsaturated fatty acids (lipid peroxidation) 
3. oxidations of amino acids in proteins 
4. oxidatively inactivate specific enzymes by oxidation of cofactors 
In the electron transport chain, electrons are transferred through a series of proteins via oxidation-
reduction reactions, with each acceptor protein along the chain having a greater reduction potential 
than the previous. The last destination for an electron along this chain is an oxygen molecule. In 
normal conditions, the oxygen is reduced to produce water. However, about 0.1–2% of electrons 
transferred through the chain (this number derives from studies in isolated mitochondria, though the 
exact rate in vivo in not fully elucidated), oxygen is instead prematurely and incompletely reduced 
to give the superoxide radical (O2
●
¯), mostly documented for complex I and complex III. 
Superoxide itself is not particularly reactive, but can inactivate specific enzymes or initiate lipid 
peroxidation in its protonated form, hydroperoxyl HO2
●
. 
The rate of O2
●
¯ production is affected by mitochondrial metabolic state and increases when the 
electron carriers harbor excess electrons, either from inhibition of oxidative phosphorylation or 
from excessive calorie consumption. The location of O2
●
¯ within mitochondria is important because 
O2
●
¯ does not diffuse across membranes. Recent studies suggest that complex I releases O2
●
¯ into 
the matrix while complex III can release O2
●
¯ into the matrix as well as the intermembrane space 
(Figure8 ).  
When O2
●
¯ is abundantly produced they are an oxidative stress. In the cell, different enzymes exist 
that can regulate this stress: 
 
Superoxide dismutases 
They are a class of enzymes that catalyze the dismutation of superoxide into oxygen and hydrogen 
peroxide. Three forms of superoxide dismutase are present. SOD1 is located in the cytosol, SOD2 
in the mitochondrion, and SOD3 is extracellular. The first is a dimer (it consists of two units), 
whereas the others are tetramers (four subunits). SOD1 and SOD3 contain copper and zinc, whereas 
SOD2 has manganese in its reactive centre. 
The SOD-catalysed dismutation of superoxide may be written with the following half-reactions: 
 M
(n+1)+
 − SOD + O2
−
 → Mn+ − SOD + O2 
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 M
n+
 − SOD + O2
−
 + 2H
+
 → M(n+1)+ − SOD + H2O2. 
Catalase 
This enzyme is concentrated in peroxisomes located next to mitochondria, reacts with the hydrogen 
peroxide to catalyze the formation of water and oxygen.  
 2 H2O2 → 2 H2O + O2 (catalase) 
Glutathione peroxidase  
It reduces hydrogen peroxide by transferring the energy of the reactive peroxides to a very small 
sulfur-containing protein called glutathione. 
 2GSH + H2O2 → GS–SG + 2H2O (glutathione peroxidase) 
 
Fig. 8 Mechanism of formation of the ROS  
Mitochondria consume nearly 85% to 90% of cellular oxygen to support oxidative phosphorylation 
by harnessing oxidized fuel to the synthesis of ATP. The energy released by the flow of electrons 
through the electron chain transport is used to pump protons out of the mitochondrial matrix 
through complexes I, III, and IV. This creates an electrochemical gradient across the mitochondrial 
inner membrane. The potential energy stored is coupled to ATP synthesis by ATP synthase. 
Oxygen normally serves as the ultimate electron acceptor and is reduced to water. However, 
electron leak to oxygen through complexes I and III can generate superoxide anion (O2
●
¯) (Figure 
8). 
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Oxidative stress can be defined by an unbalance due to an increase of ROS production and a 
decrease of anti-oxidative systems. Recently, studies have linked ROS production and oxidative 
stress to insulin resistance
72
. Indeed, insulin resistance is associated with elevated circulating levels 
of non-esterified fatty acids and it has been demonstrated an inverse correlation between the fasting 
plasma FFA concentration and ratio of reduced/oxidized glutathione (the major endogenous 
antioxidant) in type 2 diabetic patients. This correlation can be explained by an overflow of reduced 
coenzymes within the mitochondrial matrix due to an excessive lipid oxidation. The massive 
production of reduced coenzymes saturates the electron chain transport and favors the synthesis of 
ROS. The amount of available fatty acids in type 2 diabetes leads to an uncoupling of lipid 
oxidation and electron chain transfer within mitochondria and induces an increase in ROS 
production. 
Through in vitro studies and in animal models of diabetes, it has been found that antioxidants, 
especially lipoic acid (LA), improve insulin 249
73
. Several clinical studies have also demonstrated 
that treatment with vitamin E, vitamin C, or glutathione improves insulin sensitivity in insulin-
resistant individuals and/or patients with type 2 diabetes
74
 In both normal individuals and in type 2 
diabetic patients, restoration of redox balance by infusion of glutathione improves insulin sensitivity 
along with ß-cell function
75
 
In contrast, in healthy subjects, infusion of FFA (as intralipid) causes increased oxidative stress, as 
judged by increased malondialdehyde levels and a decline in the plasma reduced/oxidized 
glutathione ratio
75
. Malondialdehyde is a highly toxic by-product generated in part by lipid 
oxidation and ROS and it is increased in diabetes]. 
  
V. Mitochondrial Dysfunction and Nonalcoholic fatty liver disease   
 
Nonalcoholic fatty liver disease (NAFLD) encompasses a disease spectrum ranging from simple 
hepatic steatosis to steatohepatitis (NASH), fibrosis, and cirrhosis. NAFLD is defined as an excess 
of fat in the liver. Accumulating evidence indicates that mitochondrial dysfunction plays a central 
role in the pathogenesis of NAFLD, and that NAFLD is a mitochondrial disease
76
. 
Mitochondria play an important role in hepatocyte metabolism, being the primary site for the 
oxidation of fatty acids and oxidative phosphorylation. 
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The mitochondrial abnormalities associated with NAFLD include ultrastructural lesions, depletion 
of mitochondrial DNA (mtDNA), decreased activity of respiratory chain complexes, and impaired 
mitochondrial β-oxidation. Abnormal morphologic changes in liver mitochondria have been 
observed in patients and animal models with NASH
5
. Electronic microscopy revealed that 
mitochondria in NAFLD are big and swelled, scarce in number. 
 
Possible mechanisms implicated in the development of NAFLD: 
 
1. Excessive reactive oxygen species (ROS) production: 
This increase in the production of ROS can be explained with an increase of the β-oxidation in the 
mitochondria. ROS-induced depletion in mtDNA can severely lower mitochondrial number and 
function leading to steatosis and liver lesions. The increased ROS formation may in turn contribute 
to liver lesions through the formation of reactive, and biologically active lipid peroxidation products 
and also by increasing the formation of several cytokines, including Fas ligand, TNF-a, 
transforming growth factor-β (TGF-β), and interleukin-8 (IL-8) 
 
 
 
 
Fig. Transport of fatty acids in mitochondrion and β-oxidation 
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2. Increased TNF-α expression,  
 
Another important factor to consider in the pathogenesis of mitochondrial dysfunction is TNF-α. 
The likely sources of the hepatic TNF-α are hepatocytes and resident macrophages named Kupffer 
cells. TNF-α induces mitochondrial swelling with a lighter matrix and a loss of septa. In addition, 
TNF-α induced swelling of the mitochondria and causes a bursting of the mitochondrial membrane 
leading to an interference between complexes I and III 
77
. 
 
3. Altered PGC-1 expression. 
 
Mitochondrial functional capacity is dynamically regulated to meet the diverse energy demands 
imposed on the mammalian organism following birth. Postnatal mitochondrial biogenesis involves 
multiple signaling and transcriptional regulatory pathways that control the coordinate expression of 
nuclear and mitochondrial genes involved in mitochondrial structure, metabolism, and proliferation. 
Recent evidence points toward a transcriptional coactivator, peroxisome proliferator-activated 
receptor-γ (PPARγ) coactivator-1α (PGC-1α), as an integrator of the molecular regulatory circuitry 
involved in the transcriptional control of cellular energy metabolism, including mitochondrial 
function and biogenesis
78, 79
. 
Recent evidence also implicates PGC-1α in the homeostatic control of systemic energy metabolism. 
PGC-1α potently induces the expression of genes implicated in energy homeostasis in almost every 
cell type through known mitochondrial regulators such as the estrogen-related receptors (ERRs), 
peroxisome proliferator-activated receptor δ, or nuclear respiratory factor (NRF-1, 2)78-80. 
Overexpression of PGC- 1α in skeletal muscle cells results in an increased energy expenditure, 
mitochondrial biogenesis, whereas loss of PGC-1α results in reduced muscle performance, cardiac 
defects, and other metabolic and behavioral defects. 
Liver expresses low levels of PGC-1α and PGC-1β at normal condition, however, their expression 
is upregulated at fasting
80, 81
. PGC-1α and PGC-1β activate hepatic fatty oxidation by inducing 
expression of PPARα78, 82. 
Hepatocytes from PGC-1α deficient mice have diminished fatty acid oxidation activity and 
mitochondrial respiration rates 
78
. 
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Chapter 5 
Aim  
 
Obesity is a leading preventable cause of cardiovascular diseases worldwide, with increasing 
prevalence in adults and children, and health authorities consider it as one of the most serious public 
health problems of the 21st century. Overweight is stigmatized in the modern western societies, 
though it used to be perceived as a symbol of wealth and fertility at other times in History, and still 
is in some parts of the world.  
Along with the increase in obesity, there is an increase in the prevalence of type 2 diabetes, 
impaired glucose tolerance, atherogenic dyslipidemia (high plasma triglyceride and low HDL 
cholesterol).  
Numerous epidemiological studies and clinicals trials have revealed that fish oil and ω-3 
polyunsaturated fatty acids (PUFAs) reduce the risk of coronary heart disease. Ecosapentaenoic 
acid (EPA), one of the major ω-3 PUFAs contained in fish oil, has a variety of pharmacologycal 
effects such as lipid-lowering, anti-platelet aggregation, anti-inflammatory and anti-atherogenic. 
The aim of my thesis was to evaluate the effect of hight fat diets rich in fish oil (polyunsaturated 
fatty acids) or in lard (saturated fatty acids) on the obesity and on pathology associated with obesity 
such as hepatic steatosis and insulin resistance.  
The PhD project has been articulated in the three years in the following experimental series. 
EXPERIMENTAL SERIES 1: The attention was focused on the effect of diet rich in fish oil 
compared to diet rich in lard on the development of obesity, lipidemic parameters alterations and 
hepatic steatosis. As described in the introduction, mitochondrial function plays a central role in the 
fatty liver diseases. For this, I analysed liver mitochondrial functionality in terms of oxidative 
capacities, basal and fatty acid-induced proton leak, as well as in terms of oxidative stress induction. 
Furthermore, since growing evidences suggest that there is an association between mitochondrial 
functionality and fusion/fission process, I also analysed the effect of both high fat diets on the 
regulation of the protein involved in this process. 
EXPERIMENTAL SERIES 2: The attention was focused on the effect of diet rich in fish oil 
compared to diet rich in lard on insulin resistance development at the whole body level and at the 
skeletal muscle level. It is well known that skeletal muscle is the primary site of insulin action and 
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is thus inherently linked to the development of whole-body insulin resistance
1
. In condition of 
chronic overfeeding, when the capacity of cells to store fats in the form of triglycerides within lipid 
droplets is exceeded, endoplasmatic reticulum stress (ER-stress) is induced. ER-stressed cells 
activate apoptotic and inflammatory pathways, which trigger insulin-resistance and the release of 
chemokines and cytokines
2
. Whereas ER stress has been widely studied in pancreatic islets, liver 
and adipose tissue, where it has been proposed to be involved in the pathogenesis of diabetes, much 
less information exists about ER stress in skeletal muscle. Thus, aim of this experimental series was 
to evaluate in skeletal muscle the onset of ER-stress, inflammatory pathway and insulin resistance 
induced by high fat diet rich in lard or in fish oil. 
Furthermore, taking into account that it has been postulated that defects in mitochondrial 
performance could contribute to the development of insulin resistance
3
, I found of interest to 
analyze mitochondrial functionality in terms of respiration rates, energetic efficiency and oxidative 
stress in both subpopulation of skeletal muscle mitochondria (subsarcolemmal, SS and 
intermyofibrillar, IMF). 
 
EXPERIMENTAL SERIES 3: My results supported the beneficial effects of fish oil on the 
obesity and associated-diseases.  It is known that EPA up-regulates apelin expression in adipose 
tissue. It has also been shown in the team of Pr P. Valet that a treatment of apelin exerts beneficial 
metabolic effects in obese and insulin-resistant mice. So apelin could be a target of EPA that could 
mediate the beneficial effects observed in animals fed with fish oil, as EPA is its main component. I 
then decided, during my last year of PhD, to carry out my research in collaboration with Isabelle 
Castan-Laurell in the laboratory of the team of Pr. P. Valet in the institute of Molecular and 
Cardiovascular Medecine (I2MC) in Toulouse.in France (INSERM U1048, team 3). 
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I. EXPERIMENTAL SERIES 1 
Obesity and hepatic steatosis development in rats fed high fat diets rich in fish oil or in lard: 
role of mitochondria function and dynamic 
Omega-3 polyunsaturated fatty acids (PUFAs), found in fish and fish oil product, have been 
proposed as natural drug in the treatment of NAFLD (Xin et al (2008)) since they reduced serum 
triacylglycerols (TGs) levels increasing fatty acid oxidation reducing  liver fat. 
Since it is known that impaired mitochondrial function and oxidative stress play a central role in the 
physiopathology of non-alchoolic fatty liver disease (NAFLD)  [5]
 4
,
5
 
 
Mitochondria are involved in both fatty acid β-oxidation and oxidative phosphorylation, and at the 
same time, they are an important source of reactive oxygen species (ROS) which are considered an 
important factor in producing the hepatocyte injury associated with non-alchoolic fatty liver disease 
(5). Moreover the mitochondrial function is correlated with their structure and morphology. 
Mitochondria are dynamic organelles, undergoing to fusion and fission processes (mitochondrial 
dynamic process)
6
,
7
 Several important regulatory proteins have been identified in these processes; 
dynamim-related protein 1 (DRP-1) and fission 2 (Fis-1) have been implicated in fission (41,43 di 
Holloway PGC Am J Phys end metab 2008), whereas mitofusin-1 (MFN-1), MFN-2 and autosomal 
dominant optica atrophy-1 (OPA-1) have been suggested to coordinate fusion events (4-50 di 
Holloway 2008). Growing evidence suggests that maintaining correct mitochondrial morphology 
through the balance between mitochondrial fusion and fission may be important in the regulation of 
mammalian mitochondrial energetics and critical for cell function (16 di You PNAS 2005). In fact 
more studies evidence that reduction in mitochondrial fusion is an important etiological factor in 
development of obesity and insulin resistance.(1-14-15 da Lidell diabetes 2011). This is been 
observed in reductions in MFN2 protein in skeletal muscle are observed in obesity both in obese 
Zucker rats and in obese humans, suggesting that MFN2 expression reduction may partially explain 
the metabolic perturbations associated with obesity. (bach brand zorzano 2003 JBC).  
If there are evidences about the role of the fusion-fission imbalance in skeletal muscle 
mitochondrial dysfunction linked to insulin resistance and diabetes, features of metabolic syndrome; 
on the other hand, it is far to be clarified the link between mitochondrial dynamics and dysfunction 
in liver diseases associated with accumulation of lipids.  
The aim of this first experimental series of my PhD project was to analyze in sperimental animal 
model fed with different source of fat: 
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- the development of obesity at the total body level by the composition and energy balance 
parameters,  lipidemic parameters,  
- the development of hepatic steatosis by hepatic lipid accumulation,  hepatic mitochondrial 
function, determining oxidative rates, energy efficiency and oxidative stress and  hepatic 
mitochondrial fusion-fission balance by determining MFN2 and DRP1 contents.  
The results showed that high fat diet rich in fish oil compared to high fat diet rich in lard  induced : 
1) at the total body level, an lover obesity development associated with amelioration on parameters 
implicated in lipidic metabolism and 2) at the hepatic level, an amiolioration of development of 
hepatic steatosis associated with an decrease of the alteration in mitochondrial function as well as 
with a lower  degree of oxidative stress and hepatic lipid accumulation. 
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1. Experimental procedures  
Materials.  
All chemicals used were of analytical grade and were purchased from Sigma (St Louis, MO, USA). 
Nonfat dry milk was from Biorad laboratories (Hercules, CA, USA). 
Animals and diets.  
Male Wistar rats aged 60 days (Charles River Italia, Calco, Como, Italy) were caged singly in a 
temperature-controlled room at 24°C with a 12 h light–dark cycle. 
In a preliminary experiments, I decided to analyse the effect of high fat diet rich in lard or in fish oil 
on obesity development and hepatic steatosis after two different periods of treatment: 1) 1 week 
(short period) and 6 weeks (longer period). 
The rats were divided into three groups: 
 The first group was fed a standard diet (group N) (10.6% fat J/J) 
 The second group was fed with a high fat diet rich in lard (40% fat J/J) (group L) 
 The third group was fed with a high fat diet rich in fish oil  (40% fat J/J) (group F)  
The energetic content of standard diet was 15,88 KJ/g, while the energetic content of both high fat 
diets  was 20 KJ/g .The composition of the three diets is shown in table 1. The two high-fat diets 
were formulated to be different from the standard low-fat diet in fat and carbohydrate contribution 
to the energy value but to be identical in terms of proteins, vitamins, minerals and fibre. 
The rats were fed for 1 week. I repeated the same experimental design also for 6 weeks. The 
experimental design at 6 weeks of treatment was repeated more than one time in order to perform 
all the different experimental determinations. 
Treatment, housing, and killing of animals met the guidelines set by the Italian Health Ministry. 
At the end of the experimental period, the animals were anaesthetized by injection of chloral 
hydrate (40 mg/100 g body weight, i.p.) and blood was taken via inferior cava vein. Immediately 
after blood collection, the liver was removed for further processing.  
Body weight, energy balance and body composition 
Throughout the experimental period (both for 1 week and 6 weeks treatment), body weights and 
food intakes were monitored daily. Since body weight gains were significantly different between N, 
L and F rats only after 6 weeks of treatment. For this the  analysis of total body composition and 
energy balance were only performed in the experimental design of 6 weeks treatment. To perform 
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total body energy balance analysis the rats were divided into four groups (including 7 rats each), 
one of these groups was sacrificed at the beginning of the study to establish baseline measurements. 
(referred to as N0), while the other 3 groups were fed with the 3 different diet as above mentioned.  
Aliquots of homogenised carcass were analysed for: 
 Lipid content, by Folch method (bibliografia di Folch) 
 Water content by drying  
 Energetic content by calorimetric bomb 
In particular at the end of treatment, analyzed parameters were: 
 Body weight gain  
 Body energy, protein and fat gains 
 Metabolizable energy (ME) intake was obtained by subtracting the energy measured in 
faeces (by calorimetric bomb) and urine (4%) from the gross energy intake, determined 
from daily food consumption and gross energy density of the diets (by calorimetric 
bomb). 
 Energy efficiency was calculated as the percentage of body energy retained per ME 
intake.  
 Energy expenditure was determined as the difference between ME intake and energy 
gain.  
a. Body lipid content determination  
The lipid content was determinated by the Folch method. The aliquots of homogenised carcass were 
diluited 20 times in chloroform/methanol (2:1), followed by filtration. A solution of NaCl 0,29% 
was then added. The samples were centrifuged at 1000g for 20 minutes at room temperature to 
separate the two phases. The upper phase was removed by aspiration. The interface was rinsed two 
times with a solution chloroform/methanol/ NaCl (3:48:47) to remove non lipidic content.  Finally, 
the lower chloroform phase containing lipid was evaporated under vacuum in a rotary evaporator 
(Heidolph) and the lipid weight/g of body carcass were determined. The lipid content in kJ was 
calculated by considering the coefficient 39,2KJ/g (energy content in one gram of lipid)  
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b. Boby energy content determination  
Body energy content was determinated by calorimetric bomb (adiabatic calorimeter). The dried  
homogenate was pressed in tablets of 200 mg. The latter were placed on platinum disk and 
connected through platinum clamps to a nickel wire that carried a current I. The whole system was 
placed in a stainless steel Dewar filled by ultrapure water and thermally isolated by the 
surroundings. In order to obtain the combustion, 35 atm of O2 were inserted in the Dewar. The heat 
generated by the oxidation of the system during the combustion, results in a variation of the water 
temperature.  
Measuring the latter, the variation of enthalpy in the system can be estimated by: 
ΔH= (Q-f) / m 
Q is the heat variation determinated by  
ΔT x C 
o C is the thermic capacity of instrument which is determinated using benzoic acid as 
standard, 
o f is the amount of heat due to the nikel wire combustion,  
o m is weight of the tablet. 
c. Protein energy content determination 
The protein energy content was obtained by difference between lipid energy content and body 
energy content, using the coefficient of 23,5kJ/g (energy content in one gram of protein). 
d. Basal metabolism determination  
The basal metabolism was monitored by system (Panlab s.r.l., Cornella, Barcelona, Spain) 
composed of a four-chambered indirect open-circuit calorimeter, designed for continuous and 
simultaneous monitoring of up to four rats. Monitoring was performed for 6 hours, measurements 
were effected every 15 min, for 3 min, in each chamber. 
e. Serum parameters determination  
Serum levels of cholesterol, triglycerides and alanine aminotrasferase (ALT) were determined using 
standard procedures.  
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f. Hepatic lipid content determination 
Lipid was extracted from frozen liver tissues in chloroform: methanol by the method of Folch (12).  
g. Mitochondrila parameters analysis  
Liver mitochondria isolation procedure 
Liver was finely minced and washed in a medium containing 220 mM mannitol, 70 mM sucrose, 20 
mM HEPES, 2 mM EDTA pH 7,4 and 0.1% (w/v) fatty acid-free bovine serum albumin (BSA). 
Tissue fragments were homogenized for 1 min in a Potter Elvehjem homogenizer (Heidolph, 
Kelheim, Germany) set at 500 rpm (4 strokes/min) and filtered. The homogenate was centrifuged at 
1000 x g for 10 min and the supernatant was centrifuged at 3000 x g for 10 min. The resulting pellet 
containing mitochondria was washed twice and finally resuspended in suspension medium 
containing 80mM LiCl, 50 mM HEPES, 5 mM Tris P,  1mM EGTA  pH 7 and 0.1% (w/v) fatty 
acid free BSA. Isolated mitochondria were then used for the determination of mitochondrial protein 
mass and respiratory parameters, fatty acid oxidation rate and proton leaks, carnitine palmitoyl-
transferase system (CPT) and aconitase activity assay, and H2O2 production .  
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Determination of mitochondrial protein mass 
Mitochondrial protein mass was assessed by measuring the activity of a mitochondrial marker 
enzyme, citrate synthase (CS), in liver homogenate (expressed per g wet liver) and isolated 
mitochondria expressed (per milligram of mitochondrial proteins), according to Srere (13). The 
samples were treated with Triton 0,5% and then incubate in a buffer containing 1mM 5,5'-Dithio-
Bis (2-Nitrobenzoic Acid) DTNB, 10mM Acetil-CoA, 10 mM Oxaloacetate. The determination of 
activity CS was determinated spectrophotometrically at 412nm and the activity was calculated using 
the molar extinction coefficient (ε= 13600 M-1). 
Determination of mitochondrial respiration 
Oxygen consumption was measured polarographically with a Clark-type electrode (Yellow Springs 
Instruments, Yellow Springs, OH) at 30°C in a medium containing 30 mmol/l KCl, 6 mmol/l 
MgCl2, 75 mmol/l sucrose, 1 mmol/l EDTA, 20 mmol/l KH2PO4, pH 7.0, and 0.1% (wt/vol) fatty 
acid-free BSA. Substrates used were 10 mmol/l succinate plus 3.75 μmol/l rotenone or 40 μmol/l 
palmitoylCoA plus 2 mmol/l carnitine plus 2.5 mmol/l malate. Measurements were performed in 
the absence (state 4) and presence (state 3) of 0.6 mmol/l ADP. Respiratory control ratio (RCR) was 
calculated as the ratio between states 3 and 4.  
Measurements of basal proton leak kinetics. 
Oxygen consumption was measured polarographically with a Clark-type electrode (Yellow Springs 
Instruments) maintained at 30°C in a medium containing 30 mmol/l LiCl, 6 mmol/l MgCl2, 75 
mmol/l sucrose, 1 mmol/l EDTA, 20 mmol/l Tris-PO4, pH 7.0, and 0.1% (wt/vol) fatty acid-free 
BSA. Titration of state 4 respiration was carried out by sequential additions of up to 5 mmol/l 
malonate in the presence of 10 mmol/l succinate, 3.75 μmol/l rotenone, 2 μg/ml oligomycin, 83.3 
nmol/mg safranin O, and 80 ng/ml nigericin. Mitochondrial membrane potential recordings were 
performed in parallel with safranin O using a JASCO dual-wavelength spectrophotometer (511–533 
nm)
8
 . The absorbance readings were transformed into mV membrane potential using the Nernst 
equation: Δψ = 61 mV × log ([K+]in/[K
+
]out). Calibration curves made for each preparation were 
obtained from traces in which the extramitochondrial K
+
 level ([K
+
]out) was altered in the 0.1- to 20-
mmol/l range. The change in absorbance caused by the addition of 3 μmol/l valinomycin was 
plotted against [K
+
]out. Then, [K
+
]in was estimated by extrapolation of the line to the zero uptake 
point.  
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Measurement of palmitate-induced proton leak kinetics 
Mitochondrial membrane potential and oxygen consumption were measured as above in the 
presence of 10 mmol/l succinate, 3.75 μmol/l rotenone, 2 μg/ml oligomycin, 83.3 nmol/mg safranin 
O, and 85 μmol/l. Due to the presence of 0.1% BSA in the incubation medium, the above 
concentrations of palmitate correspond to 98 nmol/l free (not bound) fatty acid calculated using the 
equation of Richieri et al. (27). Palmitate-induced proton leak was estimated from titration of 
respiration by sequential additions of up to 600 μmol/l malonate.  
 Determination of  carnitine palmitoyl-transferase system (CPT) activity assay 
CPT system (CPT1 plus CPT2) activity was measured spectrophotometrically (at 412 nm). The 
reaction was measured by Alexon et Nedergard method (inserire bibliografia). 
Carnitine acyltransferase activity was measured as carnitine-dependent CoASH production. 
The amount of reduced CoA liberated from palmitoyl CoA by CPT was quantitated using 5,5′-
dithiobis-(2-nitrobenzoic acid) (DTNB). The mitochondria were incubated in a medium containing 
75mM Hepes, 10mM EDTA, 10mg/ml BSA, 2,5 ml Palmitoyl-CoA, 3mM DTNB. The enzyme 
activity was calculated from an E412 = 13,600/ (M *cm). 
Determination of  mitochondrial aconitase activity  
Aconitase is an iron-sulfur protein containing a [Fe4S4]
2+
 cluster that catalyzes the stereospecific 
isomerization of citrate to isocitrate via cis-aconitate. The citrate is then converted to α-
ketoglutarate in a reaction catalyzed by isocitric dehydrogenase. Whereas exposure of aconitase to 
oxidants renders the enzyme inactive, loss of aconitase activity in cells or in biological samples 
treated with pro-oxidants has been interpreted as a measure of oxidative damage. Aconitase activity  
are monitored by measuring the increase in absorbance at 340 nm associated with the formation of 
NADPH. The rate of NADPH production is proportional to aconitase activity. The samples are 
incubated at 25°C in a buffer containing 50mM Tris-HCl, 0,6 mM MnCl2, 0,2 mM NADP
+
, 30mM 
sodium-citrate, 2U/ml isocitric dehydrogenase.  
The measure was performed in presence of Triton 1%. The enzyme activity was calculated from the 
NADPH‟s molar extinction coefficient (6,22x103  M-1cm-1). 
Mitochondria hydroxy peroxide (H2O2) 
The rate of mitochondrial  H2O2 release  was assayed by following the linear increase in 
fluorescence (ex 312 nm and at 420 nm) due to the oxidation of homovanillic acid by H2O2 in the 
presence of horseradish peroxidase (using a fluorometer) (15).  
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Determination of mitochondrial dynamic protein content  
Mitochondrial protein involved in fusion process (Mitofusin 2) and in fission process (DRP1) were 
determined by western blot analysis: to this end samples of liver isolated mitochondria were 
immediately frozen in liquid nitrogen and stored at -80°C until Western Blotting analysis were 
performed. Mitofusin mouse monoclonal antibody (diluition 3:1300, Santa Cruz) and DRP rabbit 
polyclonal antibody, (diluition 1:200, SantaCruz) were used. 
h. Data statistical analysis  
Data are expressed as mean ± SE. Respiration rates at the highest membrane potential common to 
all the curves were used to test for differences in proton leak. Differences between groups were 
compared by ANOVA followed by the Newman-Keuls test to correct for multiple comparisons. 
Differences were considered statistically significant at P < 0.05. All analyses were performed using 
GraphPad Prism (GraphPad Software, San Diego, CA). 
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2. RESULTS 
a. Results of treatment with high fat diet for different period of time 
Body weigh gain and energy intake (table 2) 
Rats fed high fat diet for 1 week showed an increased energy intake  without a significative increase 
in body weight gain (table 2). After 6 weeks of treatment, L and F rats showed significantly higher 
energy intake and body weight gain compared to N rats. But F rats showed  lower body weight gain 
(21%) compared to L (table 2) 
Serum parameters (table 3) 
After 1 week of treatment no significative differences were found in triglicerides, cholesterol and 
ALT serum level among the different groups of rats (table 3). TNFα serum level was significantly 
higher both in L than in F rats compared to N, but in F rats this parameter was decrease compared to 
L. 
After 6 weeks of treatment L rats showed significantly higher level of TG (40%), cholesterol (51%), 
ALT (65%) and TNFα compared to N rats (table 3). F rats showed serum level of above parameters 
significantly lower compared to L rats and similar to N ones for TG and cholesterol levels. 
Hepatic lipid content (table 4) 
No significative differences were found in hepatic lipid content after 1 week of treatment. After 6 
week of treatment, hepatic lipid content was significantly higher (doubled) in L compared to N rats, 
and was significantly lower  in F compared to L rats. 
Hepatic oxidative stress (table 5) 
No difference in mitochondrial oxidative stress (as showed by the basal/total aconitase activity 
ratio, a sensitive marker of oxidative stress) was found after 1 week of treatment among the 
different groups of rats.  
After 6 weeks of treatment L rats showed an increase in liver mitochondrial ROS production 
compared to N ones as indicated by the decreased (15%) basal aconitase/total aconitase ratio, while 
F rats showed a similar value compared to N rats. 
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b. Results of treatment with high fat diet for 6 weeks 
Body composition and energy balance (tables 6 and 7) 
Changes in body composition, after 6 weeks of high-fat feeding, are shown in Table 6. Body energy 
and body lipid content increased in both groups treated with high fat diet, but the increase was 
higher in L rats. In fact, L rats showed significantly higher body energy (38% ) and body lipid 
content (86%) compared to N rats, while in F rats body lipid content and body energy was were 
significantly decreased .  Moreover body water and protein contents were lower in L rats compared 
to N ones (table 6). 
Table 7 shows the results concerning energy balance and partitioning of metabolisable energy 
intake after 6 weeks of treatment.   
Body energy and lipid gains were significantly higher in L and F rats compared to N rats, but were 
significantly lower in  F rats compared to L rats, while ME intakes (Table 7 ) were similar in L and 
F rats but significantly higher than in N rats. Energy expenditure was significantly increased in L 
and F rats but further increased in F rats compared to L rats. L rats showed the highest valules of 
gross efficiency (expressed as ratio body energy gain (KJ) /Metabolized energy intake)  and lipid 
gain/ME intake.  Protein gain and protein gain/ME intake were similar in L and F rats and 
significantly lower compared with N rats (Table 7). 
The results on basal metabolism by VO2, VCO2, and daily EE were significantly higher in L rats 
than in N rats while F rats showed the highest values of these parameters. RQs were similar in L 
and F rats but significantly lower compared to N rats (Table 7).  
Mitochondrial protein mass, function and dynamic 
Mitochondrial protein mass was calculated as the ratio between Citrate Synthase (CS) activity in the 
homogenate and isolated mitochondria. The results indicated that mitochondrial protein mass, was 
significantly higher in L and F rats compared to N. But CS activity measured in homogenate, 
expressed per g wet liver (table 8), was higher in F rats compared to L and N ones; while the CS 
activity measured in mitochondria, expressed per mg mitochondrial protein, was in L lower 
compared to N while in F rats this was  increased compared to L.  
As for mitochondrial functionality, State 3 and State 4 respiration rates (Table 9) obtained using 
succinate as substrate were significantly lower (23%) in L rats (vs. N) whereas in F rats the rates 
were similar to those obtained in N rats (Table 9). The fatty acid oxidation rates  (measured in the 
presence of palmitoyl-carnitine as substrate) and CPT system activity were  increased in L rats and 
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further increased in F rats (Table 9). RCR values were similar in the three groups of rats and were 
consistent with those of intact, functional isolated mitochondria.  
 
As for mitochondrial efficiency Figure 1A shows that under basal conditions  (i.e. in the absence of 
free fatty acids) (19, 20),  liver mitochondria from F rats had to consume more oxygen than N and L 
ones to maintain a given membrane potential. This indicates that F rats had an increased basal 
proton leak (compared to both N and L rats). Indeed, respiration rate measured at the highest 
membrane potential common to all the curves (170 mV) was statistically significant (P< 0.05) when 
comparing F rats with N and L ones (Figure 1B). On the other hand, basal proton leak from L rats 
was indistinguishable from N rats since the respective kinetic curves were superimposable (Figure 
1A). For fatty-acid induced proton leak (i.e., in the presence of physiological amounts of palmitate) 
among the three groups analysed, L rats had the lowest proton leak and F rats the highest one 
(Figure 1C). Indeed, respiration rates measured at the highest membrane potential common to all 
the curves (126 mV) were statistically significant (P< 0.05) between the groups (Figure 1D). 
 
The oxidative stress was evaluated after 6 weeks of treatment by measuring both aconitase activity 
(see table 5, as above mentioned) and H2O2 production (table 10). L rats showed the highest H2O2 
production compared to N and F rats (table 10).  
Mitochondrial dynamic processes were evaluated by measuring the mitochondrial protein contents 
of Mfn2 (protein involved in the fusion process) and DRP1 (protein involved in fission process) by 
western blot analysis. L rats showed the highest content of DRP1 and the lowest content of Mfn2 
while N and F rats have similar content of both proteins (figure 2). 
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TABLE 1: COMPOSITION OF DIET 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 
Purified high nitrogen casein, containing 88% protein 
b
American Institute of Nutrition (1977) 
c
American Institute of Nutrition (1980) 
d
The energy density was estimated applying the coefficients (kJ/g) 16.51,17.34 and 37.56 for 
carbohydrate, protein and fat, respectively  
Component Control diet                      High fat diet  
  Lard  Fish oil 
  g/100g diet g/100g diet 
    
Feed standard g 100 51,03 51,03 
Casein
a
 g --------- 9,25 9,25 
Lard g --------- 21,8 ------ 
Cod liver Oil g --------- --------- 21,8 
Sunflower Oil g --------- 1,24 1,24 
AIN 76Mineral mix
b
 g --------- 1,46 1,46 
AIN 76Vitamin mix
c
 g --------- 0,42 0,42 
Choline bitartrate g --------- 0,08 0,08 
Methionine g --------- 0,12 0,12 
Energy density
d
, kJ/g diet 15,88 20,00 20,00 
Energy (J/100J)    
Protein %  29 29 29 
Lipid % 10,6 40 40 
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TABLE 2: BODY WEIGHT GAIN AND ENERGY INTAKE 
 
 
 
 
 
 
 
 Data are 
means ± SE 
for 7 different rats in each experimental group. *P<0,05 compared to N rats. #P<0,05 compared to 
L rats.  
  N L F 
1 wk    
Body weight gain (g) 34,4 ± 3,0 44,2 ± 4,0 45,8 ± 5,0 
Energy intake (KJ) 3287,16± 177,9 3768,4 ± 107,8 * 3760,8 ± 120,7 * 
6 wk    
Body weight gain, g 111,6±10.0 175,0±12,0* 138,0±5,3# 
Energy intake (KJ) 13442±403 20333±508* 20306±211* 
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TABLE 3: SERIC PARAMETERS 
 
 N L F 
TG, mg/dL    
1 wk 116,5±13,6 125,2±37,4 102,8±13,4 
6 wk 100,6±4,00 142,25±2,40* 106,5±3,0# 
Cholesterol, mg/dL    
1 wk 66,2±4,7 74,2±5,2 54,8±5,2 
6 wk 47,8±1,11 72,2±8,67* 47,5±1,2# 
ALT,U/l    
1 wk 49,4±5,8 51,2±4,2 47,6±2,1 
6 wk 41,0±3,6  67,8±1,5* 54,6±1,8*# 
 
Data are means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N rats. 
#P<0,05 compared to L rats.  
TG= triglycerides. ALT= alanine aminotransferase.  
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TABLE 4: HEPATIC LIPID CONTENT 
 
Hepatic lipid 
content mg/g 
N L F 
1 wk 3.0±012 4.4±0.14 3.9±0.11 
6 wk 4.1±02 8.5±0.0.8* 5.9±0.8*# 
 
 Data are means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N rats. 
#P<0,05 compared to L rats.  
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TABLE 5: OXIDATIVE STRESS 
 
Basal aconitase 
/total aconitase 
Normal Lard Fish oil 
1 wk 0.660.06 0.560.04 0.630.07 
6 wk 0.84 0.013 0.71 0.014* 0.80 0.02# 
Data are means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N rats. 
#P<0,05 compared to L rats.  
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TABLE 5: 
Body composition  in rats fed high fat diet rich in lard or fish oil for 6 weeks. 
 Normal Lard Fish oil 
Body water (%) 62,5±0,6 54,8±2,2* 60,3±0,4# 
Body lipid (%) 11,9±0,6 22,2±1,6* 16,2±0,7*# 
Body protein (%) 18,4±0,2 15,7±0,9* 17,2±0,2 
Body energy (KJ/g) 9,0±0,2 12,4±0,5* 10,3±0,3*# 
 
Data are means ± SE for 7 different rats in each experimental group.  
*P<0,05 compared to N rats  
 #P<0,05 compared to L rats  
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TABLE 7 
Energy balance and partitioning of metabolizable energy intake in rats fed high fat diet rich in lard 
or fish oil for 6 weeks. 
  Diet  
 Normal Lard Fish oil 
ME intake (KJ) 13442±403 20333±508* 20306±211* 
Energy expenditure (KJ) 12209±450 16572±280* 18063±224*# 
Body weight gain  (KJ) 1233±162 3760±331* 2237±164*# 
Gross energy efficiency % 9±0,5 18±1,1* 11±0,8# 
Protein gain, kJ 468±30 377±30* 357±16* 
Lipid gain, kJ 864±134 3483±422* 1873±162*# 
Protein gain/ME intake(%) 3,5±0,5 1,9±0,5* 1,8±0,1* 
Lipid gain/ME intake (%) 6,4±1,0 17.1±1,7* 9,2±0,8# 
    
VO2(ml/min/kg
0,75
) 6.6±0,2 8,6±0,4* 11,8±0,9*# 
VCO2(ml/min/kg
0,75
) 6,0±0,3 7,5±0,3* 10,3±0,4*# 
RQ 0,91±0,01 0,87±0,01* 0,87±0,01* 
EE(kcal/day/kg
0,75
) 47,8±3.0 60,5±2,6* 83,0±6,1*# 
Data are means ± SE for 7 different rats in each experimental group.  
*P<0,05 compared to N rats  
 #P<0,05 compared to L rats  
ME intake = metabolizable energy intake  
VO2 = oxygen consumption; VCO2 = carbon dioxide production 
RQ= respiratory quotient; EE = energy expenditure rate 
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TABLE 8 
Citrate synthase (CS) activity and mitochondrial protein mass in rats fed a low-fat or a high 
fat diet rich in lard or fish-oil for 6 weeks . 
  Diet  
 Normal Lard Fish oil 
Homogente CS 
(μmol/min x g liver) 
 
11,9±0,7 
 
11,1±0,37 
 
15.5±0,7*# 
Mitochondria CS 
(μmol/min*mg protein). 
 
0,46±0,02 
 
0,31±0,02* 
 
0,40±0,05# 
Mitochondrial protein mass 
(mg/g wet liver) 
25,8±1,41 35,4±1,0* 38,8±3.0* 
Data are means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N 
rats  #P<0,05 compared to L rats  
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TABLE 9 
Respiratory parameters  in liver mitochondria in rats fed a low-fat or a high fat diet rich in 
lard or fish oil for 6 weeks . 
 
Respiratory parameters (state 3 and state 4) are expressed in ng atoms oxygen x min 
-1
x mg
-1
 
protein. CPT= palmitoyl carnitine transferase 
Data are means ± SE for 7 different rats in each experimental group.  
*P<0,05 compared to N rats  
 #P<0,05 compared to L rats  
 
 
  
Normal 
 
Lard 
 
Fish oil 
Mitochondria  
 
Succinate 
   
State 3 200±12 153 ± 8* 186 ± 11# 
State 4 29±3 19,5 ± 1,4* 26,4 ± 1,2# 
RCR 6,9±0,6 7,8 ± 0,6 7,1 ± 0,5 
 
Palmitoyl- CoA 
   
State 3 78,1± 5 97,7 ± 8* 121,5 ± 3,3*# 
State 4 13,0± 1.0 16.0 ± 1.0* 17,6 ±1.2* 
RCR 6,0 ± 1 6,1± 0,6 6,9± 0,8 
    
CPT in liver,  nmol 
/min x mg protein 
8,1±0,6 11,5±0,5* 14.0±0.8*# 
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Table 10 
H2O2 production in liver mitochondria in rats fed a low-fat or a high fat diet rich in lard or fish 
oil for 6 weeks . 
 
 Normal Lard Fish oil 
H2O2, nmol /min x mg 
protein 
0.208±0.02 0.261±0.001* 0.203±0,001# 
 
Data are means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N 
rats,  #P<0,05 compared to L rats  
H2O2 release
Liver  Mitochondria
Normal Lard Fish oil
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FIGURE 1 
Leak in liver mitochondria  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Basal proton leak kinetics (fig 1 A) and palmitate-induced leak kinetics (fig 1 C) in 
isolated mitochondria from N, L and F rats. Respiration rates measured by interpolation at 
179 mV (B) and 130 mV (D) for basal and palmitate-induced proton leak, respectively. Data 
are means ± SE for five different rats in each experimental groups. *P< 0.05 compared to N 
rats. #P<0.05 compared to L rats. 
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FIGURE 2 
Mitochondrial content of protein involved in fusion (Mfn2) and fission 
(DRP-1) process 
 
 
 
*P< 0.05 compared to N rats.  
* 
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3. DISCUSSION 
In the first experimental series of my PhD research project, I compared the effects of high fat 
diet rich in fish oil and high fat diet rich in lard on obesity and hepatic steatosis development. 
In a first approach, I analysed the effect of both diets for a short (1 week) and long (6 weeks) 
periods. Then, I focused on the long-term treatment to analyse its effects on hepatic steatosis 
development. Since mitochondria are known to play an important role in the development of 
hepatic disease, I analysed the mitochondrial mass, functionality and dynamic processes after 
6 weeks of treatment. 
The first experimental approach showed that energy intake was similar in rats fed with a high 
fat diet rich in lard (“Lard group”) or in fish oil (“Fish oil group”). Nevertheless these rats 
showed a higher energy intake than the rats fed with the control diet, after 1 and 6 weeks of 
treatment (table 2). The body weight gain was similar after 1 week of treatment, while the rats 
fed with lard showed the highest body weight gain after 6 weeks of treatment. Therefore, 
obesity develops after 6 weeks of high fed diets and was more evident in the Lard group 
compared to the Fish oil ones. After 1 week of treatment, there was no alteration in serum 
parameters related to lipid metabolism (TG and cholesterol) and hepatic injury (ALT) among 
the three groups of rats (table 3). The above parameters were affected after 6 weeks of 
treatment: in line with the well known antilipidemic effect of omega 3 fatty acids, TG and 
cholesterol levels in the Fish oil group were similar to those found in the rats fed with the 
control diet. The rats in the Fish oil group also showed a lower degree of hepatic injury, as 
indicated by ALT plasmatic levels, compared to the Lard group (table 3). In accordance, 
hepatic lipid accumulation was lower in the Fish oil group than in the Lard group (table 4) 
after 6 weeks of treatments. Furthermore, hepatic mitochondrial oxidative stress was evident 
only in the rats fed with lard after 6 weeks of treatments. 
 
Taken together, these first results suggested that, after 1 week of treatment, both high fat diets 
didn‟t have significant effect on obesity development, plasma lipid parameters and hepatic 
steatosis. On the other hand, after 6 weeks of treatment, obesity development, alteration of 
serum parameters, hepatic lipid accumulation and oxidative stress were mainly evident in rats 
fed a high fat diet rich in lard, while fish oil seems to have a protective or a retarding effect on 
these metabolic alterations. In the light of the above results, I decided to further investigate 
the effect of the 6 weeks treatment with high fat diet rich in fish oil on body energy balance 
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and composition, as well as on hepatic steatosis development and hepatic mitochondrial mass, 
function and dynamic processes. 
As for obesity development, the experiments on 6 weeks treatment showed that body 
composition were different among the three groups of rats, with the highest body lipid content 
in the Lard group (table 6). Furthermore, in line with a lower body weight gain (table 2), Fish 
oil fed rats exhibited a lower body energy balance and lipid gain compared to the rats fed with 
lard, even if Energy Metabolized intake were similar between the two groups of rats (table 7). 
These results could be explained by the higher energy expenditure observed in the Fish oil 
group compared to the Lard group (table 7). Therefore, the Lard group‟s excess energy intake 
was deposited as fat,as indicated by the higher lipid gain/ME intake, while the Fish oil rats‟ 
excess energy intake did not lead to fat gain thanks to the higher energy expenditure. 
Changes in thermogenesis at the whole body level reflect parallel changes at organs and 
tissues level, which are the major contributors to standard metabolic rate, such as liver. At the 
cellular level, important sites of thermogenesis are the mitochondria, due to their incomplete 
coupling between substrate oxidation and ATP production
ix
. It has been calculated that basal 
proton leak, one of the responsible mechanisms for mitochondrial uncoupling, accounts for 
about 20% of resting energy expenditure in mammals (
x
). In addition, it is well known that 
free fatty acids (FFA) are responsible for so-called mild uncoupling in mitochondria (
xi
). 
Mitochondria seem to play an important role not only in thermogenesis but also in hepatic 
steatosis development. In fact accumulating evidence indicates that impaired mitochondrial 
function plays a central role in the fatty liver disease. 
Taking into account the above consideration and the observation that the rats fed with fish oil 
showed lower hepatic lipid accumulation and oxidative damage compared to the rats fed with 
lard, I focused the attention on hepatic mitochondrial compartment by analysing 
mitochondrial protein mass, respiratory capacity and dynamic processes. 
 
The results obtained on mitochondrial function confirm that the development of ectopic fat 
storage in the liver induced by a high fat diet is associated with alterations in the 
mitochondrial compartment (
xii
), but they also suggest that the source of fat in the high fat diet 
differently affect the mitochondrial function. 
In line with the lesser hepatic fat accumulation observed (table4), fish oil fed rats showed a 
lower oxidative stress and impaired mitochondrial function, compared to the rats fed with 
lard. 
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As for mitochondrial mass, high fat diet rich in lard as well as high fat diet rich in fish oil 
induced an increase in this parameter (table 8), but it should be noted that the Lard group 
showed a decreased citrate synthase activity measured on isolated mitochondria, indicating an 
impaired mitochondrial activity. 
In addition, the rats fed with lard exhibited reduced respiratory capacity, using succinate as 
substrate (table 9) and increased oxidative stress (table 5 and 10) in their liver mitochondria 
even if the ability to use fat as metabolic fuel was elevated (in line with previous result 
bibliografia IX). The increased mitochondrial fatty acid oxidation observed in the fatty liver 
would be a compensatory mechanism for the increase hepatic uptake and synthesis of free 
fatty acid (FFAs) that occur during high-fat feeding. This also occurs in patients with 
steatohpeatitis (25, 26 by J of Hepat.) and in the liver of the genetically obese (ob/ob) mice, 
which exhibit massive steatosis. The mechanisms responsible for the increased mitochondrial 
β-oxidation observed in the fatty liver are poorly understood but the increase in substrate 
pressure, the activation of hepatic peroxisome proliferator-activated receptor alpha (PPAR-α) 
by the augmented pool of FFAs, as well as the enhanced CPT-I activity may play an 
important role, as suggested in this and in previous work (J hepat). Actually, in mitochondria 
from the liver of rats frome the Lard group, both CPT system activity and β oxidation are 
increased compared to the control rats (table 9). 
Succinate oxidation shares with lipid oxidation the pathways underlying FADH2 linked 
respiration. In line with  previous work (IX), in contrast to the significant increase in oxygen 
consumption occurring when palmitoyl-carnitine was employed as substrate, decreased 
respiratory rates were evident when respiration was supported by succinate, thus suggesting 
that FADH2 linked respiratory pathways are inhibited by high fat diet rich in lard feeding 
(table 9). Mitochondrial State 4 respiration, controlled by the activity of the respiratory chain 
and by the proton leak [31], decreased in the fatty liver, although no change in the basal 
proton leak occurred (figure 1B). This seems to support an inhibition of electron chain activity 
and a substantial role for substrate pressure in enhancing fatty acid oxidation in the liver in 
rats fed a high-fat diet rich in lard. However, this increase in lipid oxidation is apparently not 
sufficient to handle the increased load of hepatic FFAs, the result being that the remaining 
FFAs are converted into triglycerides that are partly stored in the cytoplasm, causing steatosis. 
Interestingly, our data suggest that an increase in mitochondrial energy efficiency, as shown 
by the decrease in the induced proton leak in Lard fed rats (figure 1C), also contributes to the 
fat accumulation observed in those rats.  
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High fat diet rich in fish oil induced a higher increase in CPT system activity and in β 
oxidation (table 9) than the high fat diet rich in lard, compared to the normal diet. These 
increases allow a better compensation of hepatic load of FFAs and could be one of the 
mechanism by which fish oil diet induced a lower lipid accumulation compared to a lard diet. 
In addition, the increase in respiration rates would increase the re-oxidation of NADH, a 
coenzyme required for both β oxidation and tricarboxylic acid cycle. This, together with a 
concomitant less efficient utilization of substrates, through the increase of both the basal and 
fatty acid-induced proton leak (figure 1) would lead to a greater burning of fat and reduce 
lipid accumulation in liver of F rats (table 4). The effect of high fat diet rich in fish oil on liver 
mitochondrial efficiency may be ascribed to an induction of the expression of UCP2 as been 
suggested. 
The most interesting results relate to changes in the efficiency of substrate utilization. Indeed, 
our data showing a decreased proton leak at the mitochondrial level (figure 1A), and an 
increase in body weight gain/energy intake ratio (gross efficiency, table 7) clearly indicate a 
more efficient energy utilization in Lard group than in control animals. On the other hand, 
Fish oil group rats exhibited a less efficient energy utilization as indicated by the increased 
proton leak at the mitochondrial level (figure 1), and the decreased body energy and lipid gain 
efficiency at the total body level (table 7). 
It is well known that oxidative stress plays an important role in hepatic steatosis development, 
and the lard fed rats exhibited, in addition to higher lipid accumulation, an increase in 
mitochondrial oxidative stress parameters such as an increase in H2O2 production (table 10) 
and an  inhibition of aconitase activity (table 5) compared to rats fed a normal diet. Under 
normal conditions, from 0.15% to a few percents of the total amount of oxygen consumed 
yields superoxide . When metabolic turnover increases due to an increase in the respiratory 
chain enzyme levels for instance, ROS production is increased.It should be noted that fatty 
acid β-oxidation per se can lead to significant mitochondrial ROS generation, probably by 
increasing both the amount of reducing equivalents and electron transfer within the 
respiratory chain. Large amounts of ROS are also likely to be produced via the concomitant 
increase in β-oxidation rate (which enhances NADH and FADH2 generation and thus electron 
delivery to the respiratory chain) and respiratory chain impairment (as indicated by the 
decrease in succinate State 3 oxygen consumption, which would partially block electron flow 
within the respiratory chain). Indeed, rats fed with lard exhibited higher β-oxidation rate as 
well as impairment of respiratory chain ,by using succinate as substrate, (table 9) associated to 
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higher ROS production as showed by the higher H2O2 production (table 10) and inhibition of 
aconitase activity (table 5) compared to rats fed with a normal diet (table 5). 
High fat diet rich in fish oil induced both a lower hepatic lipid accumulation and a lower 
degree of oxidative stress compared to the high fat diet rich in lard. Indeed, oxidative stress 
observed in Fish oil rats was as low as in normal rats, as showed by the H2O2 production 
(table 10) and the aconitase activity (table 5) values. These results may be partly due to the 
increased basal and fatty acid-induced proton leaks that prevent the over-reduction of 
respiratory complexes and excessive ROS formation (37). 
Taken together, the results on mitochondrial mass and functionality tend to suggest that high 
fat diet rich in fish oil did not induce the same impairment on mitochondrial activity 
(mitochondrial citrate synthase activity and damage in electron transport chain) induced by 
the high fat diet rich in lard. Moreover, high fat diet rich in fish oil induces an increase in 
mitochondrial proton leak leading to a decrease in mitochondrial efficiency which, associated 
with higher beta-oxidation and CPT activity, contribute to determine a lower degree of both 
hepatic lipid accumulation and oxidative stress. In conclusion, high fat diet rich in lard induce 
a impairment in mitochondrial function and oxidative stress, which are reduced with a high fat 
diet rich in fish oil. 
Taking into account that mitochondrial function is correlated with their structure and , and 
that they are dynamic organelles, they frequently change shape and distribution (7 I Yu 2005 
PNAS), I found of interest to evaluate the mitochondrial dynamic, which depends on the 
balance between fusion and fission events. When mitochondrial fusion is reduced, 
mitochondria fragment due to ongoing fission; conversely, mitochondria are long and overly 
interconnected when this balance shifts towards fusion. Growing evidence suggests that 
maintaining correct mitochondrial morphology through the balance between mitochondrial 
fusion and fission may be important in the regulation of mammalian mitochondrial energetics 
and critical for cell function (16 di You PNAS 2005). 
The results obtained in this thesis suggested that mitochondria from the Lard group did not 
maintain a correct balance between mitochondrial fusion and fission. Indeed, their 
mitochondria isolated from L rats exhibited a higher DRP-1 content and lower Mfn2 content 
(figure 2), suggesting a shift of dynamic processes towards fission events. On the other hand, 
mitochondria isolated from F rats showed no differences in dynamic-involved protein content 
compared to the norml rats. 
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Growing evidence suggests that reduction in mitochondrial fusion is an important etiological 
factor in development of obesity and insulin resistance whereas inhibition of fission and/or 
activation of fusion is found to counteract many of the disease phenotypes related to insulin 
resistance and diabetes.(1-14-15 da Lidell diabetes 2011). Therefore, alterations in the 
proteins involved in mitochondrial dynamics, and particularly mitofusin 2, may participate in 
the reduced mitochondrial function present in skeletal muscle in obesity and type 2 diabetes. 
The results of the present thesis suggest that also impairment of mitochondrial function 
induced by high fat diet rich in lard could be due to a shift toward mitochondrial fission. 
Interestingly, if in rats fed with high fat diet rich in fish oil, the mechanism of fission is not 
induced, mitochondrial function is not impaired and oxidative stress is not induced. 
In conclusion, the results of the present thesis showed that, in our experimental model, high 
fat diet rich in fish oil decreases obesity and hepatic steatosis development, shows a higher 
tendency to mitochondrial fusion associated with an improved mitochondrial function as well 
as a lower degree of oxidative stress and hepatic lipid accumulation.   
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II. EXPERIMENTAL SERIES 2 
Insulin resistance development in rats fed high fat diets rich in fish oil or in lard: role of 
mitochondria function and energy efficiency  
In this second experimental series of my PhD thesis, the project focused on the effect of high 
fat diet rich in fish oil compared to high fat diet rich in lard on insulin resistance development 
and on the role played by skeletal muscle mitochondria. Dietary intake of fish oil, which 
presents high amounts of n-3 fatty acids such as eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), has presented beneficial effects on diabetes, obesity and 
inflammatory diseases. 
One of the most characteristic and consistent metabolic features of the obese insulin-resistant 
state is lipid accumulation in sites other than white adipose tissue, so-called ectopic fat (4 
Stannard et al). Triglyceride accumulation in the liver and skeletal muscle is strongly 
associated with insulin resistance in these tissues. In particular, skeletal muscle is the primary 
site of insulin action and is thus inherently linked to the development of whole-body insulin 
resistance (4 Stannard et al). Ectopic fat accumulation presumably reflects a cellular mismatch 
between the sum of lipid delivery and synthesis and the sum of lipid oxidation and disposal.  
The reduced circulating adiponectin level and the leptin resistance induced by high fat diet  
act together to decrease lipid oxidation in non-adipose tissues, and this causes an ectopic 
accumulation of lipid, a lipotoxic state, and insulin resistance in non-adipose-tissue such as 
skeletal muscle (5). The altered secretion pattern, associated with elevated plasma free fatty 
acid levels, is known to modulate insulin sensitivity in skeletal muscle. Intramyocellular 
accumulation of lipids directly attenuates insulin signalling within myocytes via distinct 
kinases
xiii
. In adipose tissue as well as in liver it has been shown that, in condition of chronic 
overfeeding, when the capacity of adipocyte or hepatocyte to store fats in the form of TGs 
within lipid droplets is exceeded, ER-stress is induced
xiv
. The ER plays a crucial role in the 
production and post-translational modifications of secretory and membrane proteins. Nascent 
proteins are folded with the assistance of molecular chaperones and ER enzymes that are 
involved in disulfide-bond formation and glycosylation (
xv
). The ER also serves as a check-
point for protein quality control, with the result that misfolded or unfolded proteins are 
screened out for retrotranslocation to the cytoplasm by the machinery of ER-associated 
degradation (ERAD), and then rapidly degraded by the ubiquitin pathways. Synthesis of 
neutral lipids and phospholipids also occurs in the ER. Finally, the ER is the major storage 
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depot for calcium. Increased input of the client proteins into the ER can compromise the 
capacity of the folding apparatus and ERAD machinery, and induce ER-stress (5 review 
Barletta). ER-stress can also be induced by protein-folding inhibitors. These inhibitors include 
protein glycosylation inhibitors (e.g, tunicamycin) and reducing agents (e.g., dithiothreitol 
(DTT)) that interfere with protein disulfide-bond formation, and calcium-channel blockers 
(thapsigargin) that deplete the ER calcium stores, thereby inhibiting Ca
++
 ATPase. To cope 
with ER-stress, cells activate signaling pathways, referred to collectively as the unfolded 
protein response (UPR), that slow protein synthesis and promote protein degradation. In 
addition to selective inhibition of de novo protein synthesis, the UPR also induces the 
transcription of chaperones to assist with the unfolded-protein load. The UPR has the ultimate 
aim of cell recovery and survival, but if the ER-stress is not relieved, the UPR will induce 
death via apoptosis.  
Accumulation of unfolded or misfolded proteins is sensed by three transmembrane sensors 
in the ER (IRE-1α, ATF-6, and PERK) that are held in an inactive and inhibited state by the 
binding of intraluminal ER chaperones, especially glucose-regulated protein 78 (GRP78 or 
BiP).  Upon initiation of the UPR, GRP78 is displaced to deal with the exposed hydrophobic 
regions of the unfolded proteins (which tend to form toxic protein aggregates). The 
displacement of GRP78 frees IRE-1α, ATF-6, and PERK, which are self-activated either 
(IRE-1α or PERK) by dimerization and autophosphorylation or (ATF-6) by transfer to the 
Golgi apparatus for regulated intramembrane proteolysis (RIP). IRE-1α following its 
activation removes 26 nucleotides from X–box-binding protein-1 (XBP-1) mRNA by means 
of its cytosolic endoribonuclease activity. Spliced XBP-1s protein is a potent transcription 
factor that induces diverse target genes involved in controlling the ERAD machinery of 
unfolded or misfolded proteins. These are then retrotranslocated to the cytoplasm and rapidly 
degraded by the ubiquitin pathways. Another function of the endoribonuclease activity of  
IRE-1α is the degradation of the  mRNAs of various genes that encode for secretory and 
membrane proteins. ATF-6 translocates to the Golgi apparatus, where site 1 (S1P) and site 2 
proteases (S2P) sequentially cleave ATF-6 to release the N-terminal part of the protein. This 
then translocates to the nucleus to activate target genes that upregulate chaperones, increasing 
the folding capacity of the ER. The activated PERK phosphorylates the alpha subunit of 
eukaryotic translation initiation factor 2 (eIF2α) and this globally shuts down protein 
translation, thereby halting protein loading, while selectively increasing the translation of 
certain mRNAs such as ATF-4, which upregulates chaperones. Activated PERK also 
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phosphorylates NF-E2-related factor-2 (Nrf-2), which promotes antioxidant responses and 
maintains redox homeostasis.  
A short-lasting UPR dampens ER-stress and ensures cell survival. However, a prolonged or 
sustained UPR provokes a complex network of responses that, by recruiting tumor necrosis 
factor receptor-associated factor 2 (TRAF-2), increase ER- stress (promoting a reversal of 
translational attenuation) and activate both inflammatory (JNK-AP-1 and IKKβ –NF-kB) and 
apoptotic (caspase 3) signaling pathways. 
ER-stressed cells activate apoptotic and inflammatory pathways which trigger insulin-
resistance and the release of chemokines and cytokines. ER-stress inhibits insulin signaling by 
increasing the serine phosphorylation of IRS, and this ER-stress-induced phosphorylation is 
mediated by JNK and IKKβ. The pathways activating JNK-AP-1 and IKKβ –NF-kB lead not 
only to a  direct inhibition of insulin signaling, but also to the production of inflammatory 
mediators, such as chemokines and cytokines,  through transcriptional regulation. Whereas 
ER stress has been widely studied in pancreatic islets, liver and adipose tissue, where it has 
been proposed to be involved in the pathogenesis of diabetes, much less information exists 
about ER stress in skeletal muscle. 
Taking into account the above observations, in this experimental series together with whole-
body insulin resistance and inflammation parameters, I evaluated at the skeletal muscle level: 
 lipid accumulation 
 ER stress parameters: GRP78 and eiF2 alpha 
 inflammatory parameters: TNF α  
  insulin resistance: phosphorylated Akt (studies suggest that the serine/threonine 
kinase protein kinase B (PKB or Akt) is involved in the pathway for insulin-stimulated 
glucose transporter 4 (GLUT4) translocation and glucose uptake. In the insullin 
resistance there is a decreased insulin-stimulated Akt kinase activity) 
Additionally, combination of human and rodent studies have convincingly documented 
mitochondrial abnormalities in insulin-resistant and diabetic states, highlighting the potential 
importance of impaired mitochondrial  fat oxidation in the accumulation of ectopic fat and 
giving rise to the suggestion that mitochondrial dysfunction may be the primary defect in 
prevalent obesity-related insulin resistance.  
Taking into account the above considerations, I considered of interest to investigate skeletal 
muscle mitochondrial mass, fatty acid oxidation rate and energetic efficiency in rats fed high 
fat diet rich in lard or fish oil. 
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1. Experimental procedures  
Materials.  
All chemicals used were of analytical grade and were purchased from Sigma (St Louis, MO, 
USA). 
Animals and diets.  
Male Wistar rats aged 60 days (Charles River, Calco, Como, Italy) were caged singly in a 
temperature-controlled room at 24°C with a 12-h light–dark cycle. The rats were divided, as 
in the experimental series 1, into three groups: The rats were divided into three groups: 
 The first group was fed a standard diet (group N) (10.6% fat J/J) 
 The second group was fed with a high fat diet rich in lard (40% fat J/J) (group L) 
 The third group was fed with a high fat diet rich in fish oil  (40% fat J/J) (group F)  
The composition of the three diets is shown in table 1. The two high-fat diets were formulated 
to be different from the standard low-fat diet in fat and carbohydrate contribution to the 
energy value but to be identical in terms of proteins, vitamins, minerals and fibre. 
At the start of the study, the rats were divided into four groups with a similar mean body 
weight (about 345 g) and with the body weights normally distributed within each group. The 
treatment period lasted 6 weeks. Throughout the experimental period, body weights and food 
intakes were monitored daily. Spilled food was carefully collected and taken into account in 
the food intake calculations. 
At the end of the experimental period, the animals were anaesthetized by injection of chloral 
hydrate (40 mg/100 g body weight, i.p.) and blood was taken via inferior cava vein. 
Immediately after blood collection, the skeletal muscle was removed for further processing. 
The experimental design was repeated more than one time to allow us to carry out all the 
scheduled analysis.  
Serum parameters determination..  
Serum levels of insulin, HOMA index, Serum glucose concentration was measured by 
colorimetric enzymatic method (Pokler Italia, Genova, Italy). Serum insulin concentration 
was measured using an ELISA kit (Mercodia AB, Uppsala, Sweden) in a single assay to 
remove inter-assay variations.  
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Serum leptin, adiponectin, MCP1 and  TNFα concentrations were measured using ELISA kits 
(B-Bridge International Inc for leptin and adiponectin and Thermo scientific for TNFα). 
a. Oral glucose tolerance test (OGTT) 
OGTT was performed at the end of experimental period. 3 groups of rats N, L, F (7 rats for 
groups) were fasted for 16 h  (overnight) before oral administration of glucose (3 g/kg of body 
weight) dissolved in water. Oral administration of glucose was carried out using oral 
administration tube. Blood was collected from a small incision site at the tip of each rat's tail 
without anesthesia and plasma glucose and serum insulin levels were measured at designated 
intervals (just before 0 (basal) and 30, 60, 90, 120, 150, 180 min after glucose administration). 
Serum glucose concentration was measured by colorimetric enzymatic method (Pokler Italia, 
Genova, Italy). Serum insulin concentration was measured using an ELISA kit (Mercodia AB, 
Uppsala, Sweden) in a single assay to remove inter-assay variations. The area under the serum 
concentration-time curve (AUC) of glucose was calculated by the trapezoidal method up to 
the last measured glucose concentration in plasma. 
b. Insulin tolerance test 
Other 3 groups of rats N, L e F (7 rats for group) were fasted for 5 h and then were submitted 
to an intravenous insulin tolerance test (10 U/kg body weight of insulin, intraperitoneally ); 
samples for blood glucose measurements were collected at 0 (basal), 10, 15, 30, 45, 60, 90, 
120, 150 and 180 minutes after injection. 
c. Skeletal muscle parameters 
Skeletal muscle lipid content.  
Skeletal muscle lipid content was determined by the method of Folch [7].  
Skeletal muscle TNFα and MCP-1 levels were detected using a commercial ELISA kit 
(Thermo Scientific).BIP/GRP78, eIF2α(P), eIF2α, Akt and p-Akt protein content were 
detected by Western blot analysis. 
In order to determine Akt and p-Akt content, other 3 groups of rats N, L e F (12 rats for 
group) were fasted from 8:00  A.M. and 5 h later subgroups of rats (6 rats for group) were i.p. 
injected with insulin (10 U/kg b.w.) or an equal volume of saline vehicle. After 30 min from 
the injection, the rats were sacrificed and skeletal muscle was immediately frozen in liquid 
nitrogen and stored at -80°C until Akt Western Blotting analysis. 
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Analysis of mitochondrial parameters 
Preparation of skeletal muscle homogenate 
Hind leg muscles were freed of excess fat and connective tissue, finely minced and washed  
in a medium containing 100 mM KCl, 50 mM TRIS, pH 7.5, 5 mM MgCl2, 1 mM EDTA, 5 
mM EGTA, 0.1% (wv) fatty acid free bovine serum albumin (BSA). Tissue fragments were 
homogenized with the above medium (1:8, wv) in a Potter Elvehjem homogenizer (Heidolph, 
Kelheim, Germany) set at 500 rpm (4 strokesmin). Aliquots of the homogenate were then 
used for the determination of respiratory activities. 
 
Preparation of skeletal muscle intermyofibrillar and subsarcolemmal mitochondria 
Tissue fragments obtained as described above were homogenized with the above medium 
(1:8, wv) at 500 rpm (4 strokes min). Homogenate was then centrifuged at 1000 gav for 10 
min and the resulting precipitate was subsequently used for the preparation of the 
intermyofibrillar mitochondria. The supernatant was centrifuged at 3000 gav for 10 min and 
the pellet containing subsarcolemmal mitochondria was washed twice and resuspended in 
suspension medium (250 mM sucrose, 50 mM Tris, pH 7.5, 0.1% fatty acid-free BSA).  
The pellet from the 1000 gav centrifugation was resuspended in a small amount of 
homogenization solution and treated with protease nagarse (1 mgg tissue) for 5 min. The 
suspension was then homogenized, filtered through sterile gauze and centrifuged at 3000 gav 
for 10 min. The resulting supernatant was rapidly discarded and the pellet was resuspended 
and centrifuged at 500 gav for 10 min. The supernatant containing the intermyofibrillar 
mitochondria was centrifuged at 3000 gav for 10 min, the pellet was washed once and 
resuspended in suspension medium. 
After the isolation of mitochondria the following measurements were performed: 
- Determination of mitochondrial protein mass 
- Determination of mitochondrial respiration rates 
-  Determination of basal and palmitate-induced proton leak 
-  Determination of  carnitine palmitoyl-transferase system (CPT) activity  
- Determination of  mitochondrial aconitase activity and H2O2 production. 
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Determination of mitochondrial protein mass 
Mitochondrial protein mass was assessed by measuring the activity of a mitochondrial marker 
enzyme, citrate synthase (CS), in skeletal muscle homogenate (expressed per g wet skeletal 
muscle) and isolated SS and IMF mitochondria expressed (per milligram of mitochondrial 
proteins), according to Srere (13). The samples were treated with Triton 0,5% and then 
incubate in a buffer containing 1mM 5,5'-Dithio-Bis (2-Nitrobenzoic Acid) DTNB, 10mM 
Acetil-CoA, 10 mM Oxaloacetate. The determination of activity CS was determinated 
spectrophotometrically at 412nm and the activity was calculated using the molar extinction 
coefficient (ε= 13600 M-1). 
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Determination of mitochondrial respiration 
Oxygen consumption was measured polarographically with a Clark-type electrode (Yellow 
Springs Instruments, Yellow Springs, OH) at 30°C in a medium containing 30 mmol/l KCl, 6 
mmol/l MgCl2, 75 mmol/l sucrose, 1 mmol/l EDTA, 20 mmol/l KH2PO4, pH 7.0, and 0.1% 
(wt/vol) fatty acid-free BSA. Substrates used were 10 mmol/l succinate plus 3.75 μmol/l 
rotenone or 40 μmol/l palmitoylCoA plus 2 mmol/l carnitine plus 2.5 mmol/l malate. 
Measurements were performed in the absence (state 4) and presence (state 3) of 0.6 mmol/l 
ADP. Respiratory control ratio (RCR) was calculated as the ratio between states 3 and 4.  
Measurements of basal proton leak kinetics. 
Oxygen consumption was measured polarographically with a Clark-type electrode (Yellow 
Springs Instruments) maintained at 30°C in a medium containing 30 mmol/l LiCl, 6 mmol/l 
MgCl2, 75 mmol/l sucrose, 1 mmol/l EDTA, 20 mmol/l Tris-PO4, pH 7.0, and 0.1% (wt/vol) 
fatty acid-free BSA. Titration of state 4 respiration was carried out by sequential additions of 
up to 5 mmol/l malonate in the presence of 10 mmol/l succinate, 3.75 μmol/l rotenone, 2 
μg/ml oligomycin, 83.3 nmol/mg safranin O, and 80 ng/ml nigericin (to collapse the pH 
difference across the mitochondrial inner membrane and allow the whole of the proton-motive 
force to be represented by mitochondrial membrane potential). Mitochondrial membrane 
potential recordings were performed in parallel with safranin O using a JASCO dual-
wavelength spectrophotometer (511–533 nm). The absorbance readings were transformed into 
mV membrane potential using the Nernst equation: Δψ = 61 mV × log ([K+]in/[K
+
]out). 
Calibration curves made for each preparation were obtained from traces in which the 
extramitochondrial K
+
 level ([K
+
]out) was altered in the 0.1- to 20-mmol/l range. The change 
in absorbance caused by the addition of 3 μmol/l valinomycin was plotted against [K+]out. 
Then, [K
+
]in was estimated by extrapolation of the line to the zero uptake point.  
Measurement of palmitate-induced proton leak kinetics. 
Mitochondrial membrane potential and oxygen consumption were measured as above in the 
presence of 10 mmol/l succinate, 3.75 μmol/l rotenone, 2 μg/ml oligomycin, 83.3 nmol/mg 
safranin O, and palmitate at a concentration of 45 μmol/l for SS mitochondria or 75 μmol/l for 
IMF mitochondria. Due to the presence of 0.1% BSA in the incubation medium, the above 
concentrations of palmitate correspond to 17 (for SS mitochondria) and 62 (for IMF 
mitochondria) nmol/l free (not bound) fatty acid calculated using the equation of Richieri et 
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al. (26). Palmitate-induced proton leak was estimated from titration of respiration by 
sequential additions of up to 600 μmol/l malonate for IMF and 1 mmol/l for SS mitochondria. 
Determination of  carnitine palmitoyl-transferase system (CPT) activity assay 
CPT system (CPT1 plus CPT2) activity was measured spectrophotometrically (at 412 nm). 
The reaction was measured by Alexon et Nedergard method (inserire bibliografia). 
Carnitine acyltransferase activity was measured as carnitine-dependent CoASH production. 
The amount of reduced CoA liberated from palmitoyl CoA by CPT was quantitated using 
5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB). The mitochondria were incubated in a medium 
containing 75mM Hepes, 10mM EDTA, 10mg/ml BSA, 2,5 ml Palmitoyl-CoA, 3mM DTNB. 
The enzyme activity was calculated from an E412 = 13,600/ (M *cm). 
Determination of  mitochondrial aconitase activity  
Aconitase activity was assayed, as described for liver tissue, by measuring the increase in 
absorbance at 340 nm associated with the formation of NADPH. The rate of NADPH 
production is proportional to aconitase activity. The samples are incubated at 25°C in a buffer 
containing 50mM Tris-HCl, 0,6 mM MnCl2, 0,2 mM NADP
+
, 30mM sodium-citrate, 2U/ml 
isocitric dehydrogenase.  
The measure was performed in presence of Triton 1%. The enzyme activity was calculated 
from the NADPH‟s molar extinction coefficient (6,22x103  M-1cm-1). 
Mitochondria hydroxy peroxide (H2O2) 
The rate of mitochondrial  H2O2 release  was assayed by following the linear increase in 
fluorescence (ex 312 nm and at 420 nm) due to the oxidation of homovanillic acid by H2O2 in 
the presence of horseradish peroxidase (using a fluorometer).  
 
d. Data statistical analysis.  
Data are expressed as mean ± SE. Differences among groups were compared by ANOVA 
followed by the Newman-Keuls test to correct for multiple comparisons. Differences were 
considered statistically significant at P < 0.05. All analyses were performed using GraphPad 
Prism (GraphPad Software, San Diego, CA). Respiration rates at the highest membrane 
potential common to all the curves were used to test for differences in proton leakage. 
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2. RESULTS 
a. Body weigh gain and energy intake  
Since the experimental design was repeated more than one time to allow us to carry out all the 
scheduled analysis, body weight gain and energy intake were monitored in each experimental 
series. Table 11 showed the values obtained in one experimental design and it could be noted 
that L rats showed significantly higher energy intake (47%) and body weight gain (52%) 
compared to N rats. F rats showed a similar energy intake but lower body weight gain (26%) 
compared to L. The results were similar to that obtained in the experimental series 1 (table 2) 
and this trend was similar in each successive experimental design. 
b. Serum concentration of hormones and metabolites 
After 6 weeks of treatment L and F rats showed significantly higher serum level of glucose 
(27%) compared to N rats (table 12). Serum insulin levels and HOMA index were 
significantly higher  in L rats compared to N ones, whereas in F rats were similar to N.  L rats 
showed the highest serum level of leptin and the lowest level of adiponectin among the three 
groups of rats. As for the inflammatory parameters, serum TNF-α and MCP-1 levels were 
higher in L rats compared to N, while in F rats they were lower than in L rats (table 12). 
c.  Glucose and insulin response to oral glucose tolerance test (OGTT) 
The results of  OGTT indicate that F rats exhibited an higher glucose tolerance compared to L 
rats. As for glucose levels response to OGTT both L and F rats exhibited an higher area under 
the curve (AUC) compared to N rats (Figure 3),  while as for insulin levels response to 
OGTT, L rats showed the higher AUC compared to N and F rats (Figure 3). These results 
suggest that F rats need a lower insulin levels to keep the same glucose response to OGTT 
compared to L rats. 
Insulin-tolerance tests 
Insulin-tolerance tests revealed that the reduction in glucose levels due to insulin 
administration was lower in L and F  rats compared to  N animals and was significantly lower 
in L compared to F ( Figure 4).  
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d. Skeletal muscle metabolic parameters: lipid content and ER stress, 
inflammatory and insulin resistance parameters. 
Skeletal muscle lipid content was higher in L rats than in N and F rats, whereas no 
significative difference was found in F rats compared to N (table 13). 
As for ER stress parameters, skeletal muscle contents of GRP78 and peIF2-α, measured by 
Western blot, were significantly higher in L rats, whereas N and F rats exhibited similar 
values (table 13) 
As for inflammatory parameters, L rats showed the highest TNF-α and MCP1 content among 
the three experimental groups. No differences were found between F and N rats in the above 
parameters (table 13). 
As showed in figure 5, L rats exhibited the lowest content of insulin-induced phosphorylated-
Akt among the three groups of rats. 
e. Skeletal muscle mitochondrial parameters 
Skeletal muscle protein mass 
CS activity, measured in the homogenate and expressed per µmol/min x g wet tissue, was 
significantly higher in L and F rats compared to N  (table 14). CS specific activities, measured 
in IMF and SS mitochondria and expressed per µmol/min x mg of mitochondrial protein, 
were significantly lower in L compared to N rats, whereas no significative differences were 
found between F and N rats. As results of the above variations, mitochondrial protein mass, 
expressed in mg/g wet tissue and calculated as the ratio between CS activity in the 
homogenate and isolated mitochondria, was significantly higher in both L and F rats 
compared to  N ones (Table 14). 
Skeletal muscle IMF respiratory rates, efficiency and oxidative stress  
In skeletal muscle IMF mitochondria, state 3 and state 4 respiration rates, obtained using 
succinate as a substrate, were significantly lower in L and F rats compared to N, but 
significantly higher in F rats compared to L (Table 5). No differences were found in RCR 
values, and the values were consistent with those of intact, functional isolated mitochondria. 
There was a no significative tendency to increase in β-oxidation (as showed by state 3 and 
state 4 respiration rates obtained using palmitoyl-carnitine as substrate) in L and F rats, 
whereas no changes were found in  CPT activity (Table 15). 
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IMF mitochondrial energetic efficiency, evaluated by measuring basal and induced proton 
leak, did no change among the three groups of rats (data not shown). In addition, IMF 
mitochondria isolated from L rats showed an higher degree of oxidative stress compared to N 
and F rats, as showed by the higher H2O2 production and by the lower basal/total aconitase 
activity ratio, a sensitive marker of oxidative stress (table 15) 
Skeletal muscle SS respiratory rates, efficiency and oxidative stress  
In skeletal muscle SS mitochondria, state 3 and state 4 respiration rates obtained using 
succinate as a substrate were lower in L rats compared to N and F rats (table 16). No 
differences were found in RCR values, and the values were consistent with those of intact, 
functional isolated mitochondria. 
Fatty acid β-oxidation was higher in L and F rats compared to N ones, as showed by state 3 
respiration rates obtained using palmitoyl-carnitine as substrate. CPT activity was also higher 
in L and F rats compared to N ones (table 16). 
In SS mitochondria no difference was found in basal proton leak (Figure 6). On other hand, as 
for fatty-acid-induced proton leakage (i.e., in the presence of physiological amounts of 
palmitate), SS mitochondria from L rats had the lowest proton leakage and those from F rats 
the highest one among the three analysed groups (Figure 3B). Therefore mitochondria from L 
rats had to consume less oxygen than N and F rats to maintain a given membrane potential, as 
showed by the lowest oxygen consumption measured at the membrane potential common to 
all of the curves (160mV). On the other hand, mitochondria from F rats had to consume more 
oxygen than mitochondria from N and L rats to maintain a given membrane potential. Indeed, 
respiration rates measured at the highest membrane potential common to all of the curves 
(160mV) were significantly higher in F rats compared N and L rats (Figure 6).  
As for oxidative stress, SS mitochondria isolated from L rats showed an higher degree of 
oxidative stress compared to N and F rats, as showed by the higher H2O2 production and by 
the lower basal/total aconitase activity ratio, a sensitive marker of oxidative stress (table 16). 
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Table 11 
Body weight gain and energy intake in rats fed high fat diet rich in lard or fish oil for 6 
weeks 
 
 
 
 
Data are means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N 
rats. #P<0,05 compared to L rats.  
Table 12 
Serum concentration of hormones and metabolites in rats fed high fat diet rich in lard or fish 
oil for 6 weeks. 
 N L F 
Glucose mg/dL 84.1±2.58 106.8±5.30* 105.8±7.29* 
Insulin μg/L 0.598±0.156 1.234±0.228* 0.610±0.072# 
Homa index mU/L 2.94±0.80 7.74±1.61* 3.63±0.31# 
Leptin, ng/ml  10.7±0.9 19.2±1.2* 14.1±1.2*# 
Adiponectin, µg/ml 5.96±0.28 4.28±0.59* 6.30±0.65# 
TNF-α, ng/ml  0.112±0.01 0.207±0.02* 0.136±0.01# 
MCP1 ng/ml  2.89±0.39 7.39±0.8* 3.8±0.85# 
Data are means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N 
rats,  #P<0,05 compared to L rats  
ALT = alaninoamino transferase; TNF-α = tumour necrosis factor-α;  
MCP-1= macrophage chemoattractant protein;  
HOMA index = [Glucose (mg/dL) x Insulin (mU/L)] /405 
 
Figure 3 
  N L F 
Body weight gain, g 128.8±9,3 195.7±2,0* 162.8±5,9# 
Energy intake (KJ) 14560±403 21458±508* 21190±211* 
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Glucose and insulin response to oral glucose tolerance test (OGTT) in rats fed high fat diet 
rich in lard or fish oil for 6 weeks. 
 
 
 
 
 
 
 
 
 
 
 
  N L F 
AUC glucose  21509  ± 704 27264 ±995* 26606 ± 800* 
AUC insulin 159.8 ± 13 339.4 ± 20* 203.9 ± 10# 
Data are means ± SE for 7 different rats in each experimental group. AUC= area under the 
curve.*P<0,05 compared to N rats,  #P<0,05 compared to L rats  
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Figure 4 
Glucose response to insulin tolerance test (ITT) in rats fed high fat diet rich in lard or fish oil 
for 6 weeks. 
 
 
 
 
 
 
 
 
 
 
Data are means ± SE for 7 different rats in each experimental group. 
 
Figure 5 
Akt and P-Akt content in skeletal muscle isolated from rats fed high fat diet rich in lard or fish 
oil for 6 weeks. 
 
 
P-
Akt 
Ak
t 
                N     Ni    Ni   F       Fi      Fi      L      Li      Li 
0 30 60 90 120 150 180 210
50
100
150
N
L
F
times,min
g
lu
c
o
s
e
, 
m
g
/d
l
 102 
 
Table 13 
Lipid content, inflammatory and ER stress parameters in skeletal muscle isolated from rats 
fed high fat diet rich in lard or fish oil for 6 weeks. 
 N L F 
Skeletal muscle lipid 
content mg/g 
1.35 ± 0.15 1.94 ± 0.16
* 
1.47 ± 0.11
# 
Skeletal muscle TNF-α, 
ng/g 
4.95±0.25 6.02±0.2* 5.0±0.35# 
Muscle MCP1 ng/g 6.53±0.09 8.9±0.6* 6.01±0.8# 
GRP78, arbitrary 
units/mg protein 
124±6 152±11* 102±9# 
eIF2α(P)/eIF2α 301.8±50.8 673.4±54* 328.5±69.2# 
Data are means ± SE for 7 different rats in each experimental group.  
*P<0,05 compared to rats N 
 #P<0,05 compared to rats L 
TNF-α = tumour necrosis factor-α; 
MCP-1= macrophage chemoattractant protein  
GRP78=78-kDa glucose-regulated protein, also called BIP (binding protein) 
eIF2α =Eukaryotic initiation factor 2α 
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Table 14 
Mitochondrial protein mass determinated by citrate synthase (CS) activity in skeletal muscle 
homogenate and SS and IMF mitochondria in rats fed high fat diet rich in lard or fish oil for 6 
weeks. 
 N L F 
Homogenate CS activity (μmol/min x g wet 
tissue) 
15.6±1.1 18.75±0,9* 20.75±1.0* 
IMF Mitochondria CS activity (μmol/min x 
mg protein). 
1.93±0,1 1.48±0,09* 1.78±0,03# 
SS Mitochondria CS activity (μmol/min x 
mg protein 
2.3±0,09 2.0±0,03* 2.43±0,03# 
IMF Mitochondrial protein mass (mg/g wet 
tissue) 
8.3±0.8 12.8±0.6* 11.7±0.5* 
SS Mitochondrial protein mass (mg/g wet 
tissue) 
6.8±0.2 9.3±0.26* 8.6±0.4* 
 
Data are means ± SE for 7 different rats in each experimental group.  
*P<0,05 compared to rats N 
 #P<0,05 compared to rats L 
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Table 15 
Respiratory parameters, carnitine palmitoyl transferase and  oxidative stress in IMF muscle 
mitochondria isolated from rats fed high fat diet rich in lard or in fish oil for 6 weeks. 
Respiratory parameters are expressed as ng atoms oxygen x min
-1
x mg protein
-1
. Data are 
means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N rats; 
#P<0,05 compared to L rats. CPT = carnitine palmitoyl transferase; H2O2 = hydrogen 
peroxide. 
 N L F 
Respiratory parameters    
Succinate    
State 3 599±15 414±20* 470±13*# 
State 4 100±6 67±2* 80±3*# 
RCR 6.0±0.5 6.1±0.4 6.3±0.5 
Palmitoyl-Carnitina    
State 3 122±10 144±13 144±10 
State 4 24±1.5 26.1±1.4 26.6±2.4 
RCR 5.1±0.3 5.5±0.4 5.6±0.5 
    
CPT, nmol/min x mg protein 13.1±0.64 11.2±0.5 13.4±1.38 
Oxidative stress parameters    
Basal aconitase/total aconitase 0.83±0.01 0.76±0.01* 0.80±0.01# 
H2O2  nmol/min*mg protein 1.29±0.04 1.71±0.05* 1.16±0.10# 
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Table 16 
Respiratory parameters, carnitine palmitoyl transferase and oxidative stress parameters in SS 
muscle mitochondria isolated from rats fed high fat diet rich in lard or in fish oil for 6 weeks. 
Respiratory parameters are expressed as ng atoms oxygen x min
-1
x mg protein
-1
.Data are 
means ± SE for 7 different rats in each experimental group. *P<0,05 compared to N rats; 
#P<0,05 compared to L rats. CPT = carnitine palmitoyl transferase;. H2O2 = hydrogen 
peroxide. 
 N L F 
Respiratory parameters    
Succinate    
State 3 311±3,3 270±6,6* 325±15# 
State 4 55,6±2 48±1,1* 53±1.2# 
RCR 5,6±0,2 5,6±0,5 6,1±0,6 
Palmitoyl-Carnitina    
State 3 100±3,2 127±8,0* 123±3,7* 
State 4 22,5±1,5 25,4±5,4 23±2,9 
RCR 4,4±0,3 5,0±0,6 5,3±0,5 
    
CPT, nmol/min x mg protein 12,1±1 21,4±2* 18,7±1,2* 
Oxidative stress parameters    
Basal aconitase/total aconitase 0,81±0,02 0,70±0,01* 0,81±0,003# 
H2O2  nmol/min*mg protein 0,78±0,02 1,03±0,03* 0,76±0,12# 
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FIGURE 6 
Basal and fatty acid-induced proton leak in SS muscle mitochondria isolated from rats fed 
high fat diet rich in lard or in fish oil for 6 weeks 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Data are means ± SE for 7 different rats in each experimental group. 
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3. DISCUSSION  
In the second experimental series of my PhD research project, I compared the effects of high 
fat diet rich in fish oil and high fat diet rich in lard on insulin resistance development and 
skeletal muscle mitochondrial function, taking into account that skeletal muscle is the primary 
of insulin action. Thus, it is inherently linked to development of whole-body insulin 
resistance. 
As for obesity development the results were similar to those obtained in the first experimental 
series, F rats showed the same high energy intake but exhibited a lower weight gain compared 
to L rats, thus suggesting that high fat diet rich in fish oil elicit a less degree of obesity 
development compared to high fat diet rich in lard (table 11). L rats together with obesity 
development also showed whole-body insulin resistance development as demonstrated by 
higher HOMA index (table 12), higher serum levels of insulin in response to OGTT (figure 3) 
and lower decrease of serum glucose levels in response to ITT (figure 4) compared to N rats. 
On the other hand, F rats exhibited a lower degree of insulin resistance compared to L rats, as 
showed by HOMA index values and serum insulin levels in response to OGTT similar to 
those found in N rats as well as by higher decrease of serum glucose levels in response to ITT 
compared to L rats. 
Accumulating evidence indicates that obesity causes chronic low-grade inflammation and that 
this contribute to systemic metabolic dysfunction that is associated with obesity-linked 
disorders
xvi
. Adipose tissue function as a key endocrine organ by releasing multiple bioatctive 
substances, known as adipose-derived secreted factors or adipokines, that have pro-
inflammatory or anti-inflammatory activities. Dysregulation of these adipokines owing to 
adipose tissue dysfunction can contribute to the pathogenesis of obesity-linked complications. 
To gain insight into the effect of dietary fat composition on the onset of the low-grade 
inflammation at the whole body level, inflammatory parameters (TNF-α and MCP1) and 
adipokines levels (leptin and adiponectin) were measured in serum from rats fed high fat diet 
rich in lard or in fish oil. L rats exhibited higher TNF-α and MCP1 serum levels compared to 
N rats, whereas in F rats these parameters were only not significantly enhanced compared to 
N rats. Thus, high fat diet rich in fish oil elicited a low degree of inflammation at the whole 
body level compared to high fat diet rich in lard. In addition, as for adipokines levels, high fat 
diet rich in lard induced a significant decrease in adiponectin and a significant increase in 
leptin serum levels, suggesting adipose tissue dysfunction in the production and/or secretion 
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of these adipokines. On the other hand, high fat diet rich in fish oil induced no change in 
adiponectin serum levels and a lower increase in leptin serum levels compared to high fat diet 
rich in lard, suggesting a lower degree of adipose tissue dysfunction.  
The reduced circulating adiponectin level and the leptin resistance induced by high fat diet  
act together to decrease lipid oxidation in non-adipose tissues, and this causes an ectopic 
accumulation of lipid, a lipotoxic state, and insulin resistance in non-adipose-tissue such as 
skeletal muscle (5). The altered secretion pattern, associated with elevated plasma free fatty 
acid levels, is known to modulate insulin sensitivity in skeletal muscle. Intramyocellular 
accumulation of lipids directly attenuates insulin signalling within myocytes via distinct 
kinases
xvii
. In adipose tissue as well as in liver it has been shown that, in condition of chronic 
overfeeding, when the capacity of adipocyte or hepatocyte to store fats in the form of TGs 
within lipid droplets is exceeded, ER-stress is induced (38 Lionetti et al). ER-stressed cells 
activate apoptotic and inflammatory pathways which trigger insulin-resistance and the release 
of chemokines and cytokines.  
Taking into account the above observations, in this experimental series together with whole-
body insulin resistance and inflammation parameters, I evaluated at the skeletal muscle level: 
 lipid accumulation 
 ER stress parameters: GRP78 and eiF2 alpha 
 inflammatory parameters: TNF α  
  insulin resistance: phosphorylated Akt 
As for skeletal muscle lipid accumulation, high fat diet rich in lard elicited higher lipid 
content compared to control diet and high fat diet rich in fish oil. F rats showed a similar 
skeletal muscle lipid content compared to N ones (table 13). 
Associated with the higher lipid accumulation, skeletal muscle isolated from rats fed high fat 
diet rich in lard also exhibited, as expected, a higher degree of ER stress compared to the 
other two groups of rats, as showed by the higher GRP78 content as well as by the higher 
ratio eIF2α(P)/eIF2α (table 13). ER stress induced inflammatory and insulin resistance 
pathways in skeletal muscle isolated from rats fed high fat diet rich in lard, as showed by the 
highest skeletal muscle TNF-α content and the lower p-AKT content found in these rats (table 
13, figure 5).  
As suggested so far by the results, high fat diet rich in fish oil, differently from high fat diet 
rich in lard, did not induce excessive lipid accumulation in skeletal muscle, preserving this 
tissue from ER stress, inflammation and insulin resistance development. 
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In order to understand the mechanism by which high fat diet rich in fish oil did not induce 
excessive lipid accumulation in skeletal muscle, I found of interest to analyse the mass and 
functionality of mitochondrial compartment. To this purpose, analyses were carried out, 
taking into account that the skeletal muscle population is heterogeneous for localization, 
function and regulation (
xviii
). In fact, mitochondria located beneath the sarcolemmal 
membrane (subsarcolemmal, SS) exhibit lower respiratory rates than those located between 
the myofibrils (intermyofibrillar, IMF).  
The results of the present thesis showed that both high fat diet rich in lard and fish oil elicited 
an increase in mitochondrial protein mass in both SS and IMF mitochondria (table 14). 
However, specific citrate synthase activities in SS and IMF mitochondria were impaired in L 
rats compared to N and F rats. 
IMF mitochondrial subpopulation seemed not to be particularly influenced by both high fat 
diets, since no difference were found in fatty acid oxidation rates, CPT activity (table 15) and 
energetic efficiency in terms of basal and fatty acid proton leak (data not shown). However, 
impairment in electron transport chain (as showed by decreased succinate-induced respiration 
rates) was mainly found in L rats as well as increased oxidative stress was found only in L 
rats, as showed by the higher H2O2 production and by the lower basal/total aconitase activity 
ratio (table 15). 
SS mitochondria seemed to be more affected by the high fat diet treatment. Indeed, L rats 
exhibited reduced respiratory capacity (using succinate as substrate, table 16) and increased 
oxidative stress (table 16) in their SS mitochondria compared to N rats even if the ability to 
utilise fat as metabolic fuel was elevated. The increased mitochondrial fatty acid oxidation 
observed would be a compensatory mechanism for the increase substrates pressure that occurs 
during high-fat feeding. Together with enhanced fatty acid oxidation, SS mitochondria from L 
rats showed also enhanced CPT activity compared to control rats. (table 16).  
Succinate oxidation shares with lipid oxidation the pathways underlying FADH2 linked 
respiration. In contrast to the significant increase in oxygen consumption occurring when 
palmitoyl-carnitine was employed as substrate, decreased respiratory rates were evident when 
respiration was supported by succinate, thus suggesting that FADH2 linked respiratory 
pathways are inhibited by high-fat rich in lard diet feeding (table 16). Mitochondrial State 4 
respiration, controlled by the activity of the respiratory chain and by the proton leak [33], 
decreased in SS mitochondria, although no change in the basal proton leak occurred (figure 
6). This seems to support an inhibition of electron chain activity and a substantial role for 
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substrate pressure in enhancing fatty acid oxidation in SS mitochondria in rats fed a high-fat 
diet rich in lard. However, this increase in lipid oxidation is apparently not sufficient to handle 
the increased load of hepatic FFAs, the result being that the remaining FFAs are converted 
into triglycerides that are partly stored in the cytoplasm, as showed by the enhanced skeletal 
muscle lipid accumulation (table 13). Interestingly, our data suggest that an increase in 
mitochondrial energy efficiency, as shown by the decrease in the induced proton leak in L rats 
(figure 6), could also contribute to the skeletal muscle fat accumulation observed in L rats.  
High fat diet rich in fish oil and in lard induced a similar increase in CPT system activity and 
in fatty acid oxidation (table 16) in SS mitochondria compared to N rats. However, in L rats 
there was a more efficient utilization of substrates as showed by the decreased fatty acid-
induced proton leak (figure 6), whereas in F rats there was a less efficient utilization of 
substrates, through the increase of fatty acid-induced proton leak (figure 6.). This less 
efficient utilization of substrate would lead to a greater burning of fat and reduce lipid 
accumulation in skeletal muscle of F rats (table 13). 
In addition to higher lipid accumulation, L rats showed also an increase in SS mitochondrial 
oxidative stress parameters such as an increase in H2O2 production (table 10) and inhibition of 
aconitase activity (table 6) compared to N rats. It should be noted that fatty acid β-oxidation 
per se  which can lead to significant mitochondrial ROS generation, probably by increasing 
both the amount of reducing equivalents and electron transfer within the respiratory chain. 
Large amount of ROS are also likely to be produced via the concomitant increase in β-
oxidation rate (which enhances NADH and FADH2 generation and thus electron delivery to 
the respiratory chain) and respiratory chain impairment (as indicated by the decrease in 
succinate induced oxygen consumption, which would partially block electron flow within the 
respiratory chain). Indeed, SS mitochondria from L rats exhibited higher β-oxidation rate as 
well as impairment of respiratory chain (by using succinate as substrate, table 16) associated 
to higher ROS production as showed by the higher H2O2 production and inhibition of 
aconitase activity (table 16) compared to N rats.  
High fat diet rich in fish oil induced both a lower hepatic lipid accumulation and a lower 
degree of oxidative stress compared to L rats. Indeed, oxidative stress found in SS 
mitochondria from F rats was similar to that found in N rats and lower compared to L rats, as 
showed by H2O2 production (table 10) and aconitase activity (table 5) values. These results 
may be partly due to the increased fatty acid-induced proton leaks that prevent the over-
reduction of respiratory complexes and excessive ROS formation (36). 
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Taken together the results on mitochondrial functionality and oxidative stress, it could be 
suggested that high fat diet rich in fish oil did not induce the same impairment on 
mitochondrial activity (mitochondrial citrate synthase activity and damage in electron 
transport chain) induced by high fat diet rich in lard. Moreover, high fat diet rich in fish oil 
induce an increase in mitochondrial proton leak and so a decrease in mitochondrial efficiency 
that, associated with higher beta-oxidation and CPT activity, contribute to determine a lower 
degree of both lipid accumulation and oxidative stress. In conclusion, high fat diet rich in lard 
induce a higher impairment in mitochondrial function and oxidative stress, mainly in SS 
mitochondria.  
A possible explanation for the different effect of high fat diet on SS and IMF mitochondria 
could be that these two mitochondrial populations have different cellular localization and 
subserve different metabolic role in the cells. In fact, IMF mitochondria mainly meet ATP 
requirements of the contractile elements, while SS mitochondria supply ATP for cytoplasmic 
reaction.  
Thus, SS mitochondria due to their localization are the first to be affected by the substrate 
pressure caused by chronic overfeeding with high fat diet. High fat diet rich in fish oil by 
inducing an increase in fatty acid induced proton leak, elicited to an increased substrates 
utilization preventing skeletal muscle fat accumulation. The lower fat accumulation found in 
rats fed high fat diet rich in fish oil, differently from rats fed high fat diet rich in lard, did not 
induce ER stress and thus inflammatory and insulin resistance pathways.  
The results of my thesis suggest a role for omega 3 in fish oil in preventing not only obesity 
and hepatic steatosis development but also insulin resistance onset. Mitochondria seems to 
play an important role both in liver than in skeletal muscle, since by modulating respiratory 
capacity and proton leak conductance, regulate the balance between the oxidation and the 
accumulation of fat substrates. The excessive intracellular fat accumulation is then 
responsible for ER stress and the following inflammatory process and insulin resistance on-
set. Fish oil, differently from lard, by acting on mitochondrial energetic efficiency in liver and 
in skeletal muscle, is able to prevent steatosis and insulin resistance development. 
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III. EXPERIMENTAL SERIES 3 
Effect of EPA on the expression of Apelin in vitro e in vivo  
Different studies have showen that the Eicosapentaenoic acid (EPA), a polyunsaturated fatty 
acid (PUFA) from the omega-3 family, increases basal and insulin-stimulated apelin secretion 
and gene expression in 3T3-L1 adipocytes [34]. Moreover, rats fed a cafeteria diet daily 
treated with oral administration of EPA ethyl ester show a higher expression of apelin in 
adipose tissue [35]. However, the regulation of apelin by EPA in other tissues is not known.  
Thus, the aim of my project was to study the effect of EPA on apelin expression in skeletal 
muscles by an in vitro approach, using a muscular cell line (C2C12 cells) and in vivo with 
mice fed a high-fat diet supplemented, or not, with EPA. Furthermore, since like EPA, apelin 
treatment has beneficial effects on obesity and insulin sensitivity, we also studied the effect of 
a two-weeks-long apelin treatment in mice fed with EPA in order to know whether these 
molecules can have additive or synergic effects.  
 
1. EXPERIMENTAL PROCEDURES  
a. In Vitro experiments 
Cell Culture C2C12  
The cells were cultured in DMEM 4.5 g glucose / L (with Penicillin Streptomycin), 
containing 10% FCS. The medium was changed every 2 days. When 80% confluence were 
reached, medium was changed to DMEM PS containing 2% horse serum (instead of 10% 
FCS) in order to induce the differentiation into myotubes (4 days with medium change after 2 
days). A maintenance Petri dish (10 cm diameter) was seeded with 100,000 cells. Twelve-
wells plates were seeded with 10,000 cells per well at 80% confluence after 3 days. 
EPA stock solutions (10 mM) were prepared in absolute ethanol and stored at -20°C in a glass 
vial in the dark. Working solutions were prepared by adding the required volume of EPA 
stock solution to pre-warmed (37°C) DMEM containing 4% (w/v) fatty acid-free BSA. 
Dilutions were maintained at 37°C for at least 1 h before their addition to cell cultures. 
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mRNA Expression  
The cells were lysed using a buffer containing cold PBS and 1% β-Mercaptoethanol. 
Total RNAs (500ng) were isolated using Gene Jet RNA Purification kit (Fermentas) 
following manifacture instruction.  
 
RT-PCR 
Reverse transcription was performed with 500ng RNA and semi quantitative PCR was 
performed as previously described (as in the mice protocol). 
 
b. In vivo experiments : Mice fed with High Fat Diet +/- EPA 
Materials.  
All chemicals used were of analytical grade and were purchased from Sigma (St Louis, MO, 
USA). 
 
Animals and diets 
Male  C57Bl6/J mice ( JANVIER, France) were housed conventionally in a constant 
temperature (20–22°C) and humidity, with a 12h light-dark cycle and free access to food and 
water. 
 The mice were divided into three groups:  
 The first group (N) was fed with a standard diet. 
 The second group (HFD) was fed with a high fat diet containing 45% fat. This diet 
contains vitamin E, since this vitamin is present in the high fat diet enriched in EPA in 
order to avoid EPA degradation. 
 The third group (EPA) was fed with a high fat diet rich in EPA plus vitamin E (45% 
fat)  
The mice were fed for 10 wk.  
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After 8 weeks of treatment, the mice fed with the  high fat diet rich in EPA were divided into 
three groups : 
- A group received an intraperitoneal injection of pelin (0,1µmol/kg/d) 
- A group  received an intraperitoneal injection of PBS. 
- A group didn‟t receive any injection. 
The third group was created in order to check that findings depended only on the 
substance given, and not on the post-injection stress. 
Animals were handled in accordance with the principles and guidelines established by the 
National Institute of Medical Research (INSERM). All protocols were approved by the 
local ethics commitee obtained from inserm. 
At the end of the experimental period, the animals were killed after a 7 hour fast, by 
cervical dislocation. Blood was taken from the portal vein, and plasma aliquots were 
obtained after a 10 minutes centrifugation at 13,000 rpm at 4°C. The organs were 
harvested and stored at -80°C until analyzed. A fresh piece of 50mg of liver and a muscle 
(soleus) were directly used for the measurement of palmitate β-oxidation.  
 
Body weight and body composition 
 
Throughout the experimental period (10 weeks), body weight was monitored weekly. To 
determine the percentage of fat and lean mass, mice were placed in a clear plastic holder 
without anesthesia or sedation and inserted into the EchoMRI-3-in-1 system from Echo 
medical systems (Houston, TX, USA). Total body fat and lean mass were measured in all 
mice after 8 and 10 weeks of the high fat feeding. These days match with the beginning (day 
0) and the end (day 14) of the treatment with apelin injections. 
Serum parameters determination  
 
Fasting plasma insulin concentrations were determined using an ELISA Kit (Mercodia, 
Uppsala, Sweden). Fasted glycemia was measured on blood from the tail vein with a 
glucometer (Accu-check, Roche Diagnostics). 
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Hepatic triglycerides content 
Lipid content was extracted from frozen liver tissue in chloroform:methanol by the method of 
Folch, and the hepatic triglycerides content was determined by an enzymatic colorimetric 
technique using the PAP 150 Kit (BioMérieux, France). 
 
 
Liver and skeletal muscle palmitate β-oxidation  
The soleus and liver were placed in 20 ml glass reaction vial containing 2.5 ml of warmed 
(37°C), pre-gazed (95%O2 - 5%CO2, pH 7.4), modified Krebs-Henseleit buffer containing 
1.5%FA-free BSA, 5mM glucose, 1mM palmitate and 0.5μCi/ml [14C]palmitate (Perkin 
Elmer) for 60 min. At the end of the incubation, explants were removed and placed in a tube 
containing 800μl of lysis buffer. A 0.5ml microtube containing 300μl of benzethonium 
hydroxide (Sigma) was placed in the vial to capture the 
14
CO2 produced by the oxidation of 
palmitate. The incubation buffer was then acidified with 1ml of 1M H2SO4 and the vial was 
quickly sealed with parafilm. After 120 minutes, the microtube was removed and placed in a 
scintillation vial and the radioactivity, corresponding to complete oxidation, was counted 
(cytoscint. MP Biomedicals). To determine the incomplete oxidation, the explants were 
homogenized in the lysis buffer. 500μl of this homogenate were placed into glass tubes 
containing 2.5 ml of chloroform-methanol (2:1). Samples were then shaken for 10 min and 
1.2 ml of 2M KCl-HCL was added. Samples were shaken for another 10 min and centrifuged 
at 2500g for 10min. The aqueous phase (500μl) was quantified by liquid scintillation to 
determine the acid soluble metabolites (ASM). 
 
RNA extraction 
Tissues from fed mice (AT and muscle) were crushed by using a Precellys 24 automated 
biological sample lyser with CK-14 bead vials. Total RNAs were isolated from liver, adipose 
tissues and gastrocnemius muscle using an extraction kit (Fermentas).  
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RT-PCR 
Total RNAs (500ng) were reverse transcribed using random hexamers and Superscript II 
reverse transcriptase (Invitrogen). 
PCR was performed as previously described (2). Briefly, real-time PCR was performed on 
cDNA after a 1/10 dilution of the RT product, with both sense and antisense oligonucleotides 
in a final volume of 20 μl using Mesablue qPCR mastermix (Eurogentec, Seraing, Belgium).. 
In parallel, analysis of the 18S ribosomal gene was performed using the ribosomal RNA 
control Taqman Assay Kit (Applied Biosystems) to normalize gene expression. 
 
Statistical analysis.  
Data are presented as means ± SEM. Comparisons between groups were carried out for 
different parameters using Prism 5.0 software (GraphPad Software). A two 
way ANOVA was applied to detect interaction between treatment and time. When 
appropriate, Student‟s t test paired or nonpaired was applied. Differences at P<0.05 were 
considered to be statistically significant. 
 
 
2. RESULTS  
a. Effect of EPA treatment on differentiated myofibroblasts 
 Differentiated C2C12 treated with EPA at different concentrations (50mM and 100mM) and 
time of treatment (8h and 24) showed an increased apelin expression after the 24h treatment 
compared to 8h. Effects of EPA on expression of TNF α were observed after 24h, additionally 
the results showed an increase in the expression of PPARα.  
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b. Results of treatment with high fat diet rich in EPA plus Apelin 
treatment 
Body weight gain  (figure X) 
After 10 weeks of high-fat feeding, body weight gain was increased in HFD mice compared 
to control mice. However, body weight gain was significantly lower in mice fed with EPA 
compared to HFD mice. However, the two weeks long apelin treatment in addition to EPA did 
not modify the body weight gain. 
Body composition(figure X) 
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The results on body composition determined by EchoMRI show an significant decrease in the 
fat mass in mice fed EPA compared to mice fed with HFD. Again, in apelin-treated mice fed 
EPA, there was no significant difference between the PBS and Apelin groups. 
At sacrifice, there was also a difference in the weight of subcutaneous, perigonadal and 
visceral adipose depots between mice fed with EPA and mice fed with HFD but not in apelin-
treated mice. Of note, the weight of the liver and its steatosed aspect (data not shown) were 
also significantly decreased. 
Serum levels of hormones and metabolites(figure X) 
- Glycemia has been measured in fasted mice, before the sacrifice. As expected mice fed 
with HFD showed a hyperglycemia compared to control mice. However, mice fed 
with the high-fat diet rich in EPA had a significant decrease in glycemia compared  to 
HFD mice. In apelin-treated mice however, no further decrease of glycemia was 
observed. 
- Insulinemia: HFD fed mice were also hyperinsulinemic compared to chow fed mice 
but in EPA mice, the insulinemia was significantly reduced compared to HFD mice. 
Interestingly, apelin treatment had also an effect of insulinemia. 
Hepatic Triglycerides content(figure X) 
Mice fed with HFD showed a significant increase in triglycerides content compared to control 
mice, while mice fed with EPA showed a lower triglycerides content than HFD. 
 
SREBP 1c mRNA expression (figure X) 
The mRNA expression of SREBP-1c was significantly increased in mice fed with HFD 
compared to normal diets, whereas EPA mice displayed a lesser level of expression than the 
HFD mice. 
Fatty acid β-oxidation  
In the liver, the complete β-oxidation was decreased in HFD mice compared to control mice, 
whereas there was no difference in the incomplete β-oxidation. Unexpectedly, complete β-
oxidation was further decreased in EPA mice. There was no significant difference in both the 
complete and incomplete β-oxidation in the apelin-treated mice. 
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In the skeletal muscle, no significant difference in the complete and incomplete β-oxidation in 
EPA mice compared to HFD and control mice was observed. Here, apelin treatment induced 
an increase in complete β-oxidation compared to the PBS-treated mice. 
Apelin mRNA expression  
Apelin expression was decreased in adipose tissue of EPA mice compared to HFD mice but 
tend to increase compared to chow fed mice. In muscle, the same profile was observed. 
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FIGURES 13-18 
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 FIGURE18 
                                 
 
 
 
 
 124 
 
FIGURE 19 
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FIGURE 20 
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3. DISCUSSION  
In the light of the previous results of my PhD showing a beneficial effect of fish oil on 
obesity, hepatic steatosis and insulin resistance development, in the last year of my PhD I 
found of interest to evaluate the effect of polyunsaturated fatty acids (such as EPA of which 
fish oil is rich) on a new adipokine linked to obesity and insulin resistance, apelin. To this 
end, I carried out my research in collaboration with Pr. Isabelle Castan-Laurell in the team of 
Pr. Philippe Valet in the Institut des Maladies Métaboliques et Cardiovasculaires (I2MC) in 
Toulouse, France (INSERM U1048, team 3).  
  
One part of the team‟s research activity is devoted to the metabolic effects of apelin. This 
team has revealed apelin as a new adipokine  and studied its regulation by different factors in 
adipocytes (Insulin, TNFa, PGC1a). Moreover Dray et al  in the team demonstrated that 
apelin was able to stimulate AMPK activation in skeletal muscle and that apelin induced 
glucose transport in an AMPK-dependent manner. Interestingly, the effects of apelin in obese 
and insulin resistant mice are maintained and different studies have shown that apelin 
treatment ameliorates insulin sensitivity. 
Different studies have shown that EPA increased basal and insulin-stimulated apelin secretion 
and gene expression in 3T3-L1 adipocytes. Moreover, rats fed a cafeteria diet daily treated 
with oral administration of EPA ethyl ester had also a higher expression of apelin in adipose 
tissue. However, the regulation of apelin by EPA in other tissues is not known.  
Thus, the aim of my project was to study the effect of EPA on apelin expression in skeletal 
muscles by an approach in vitro in a muscular cell line (C2C12 cells) and in vivo in mice fed 
a high-fat diet supplemented (or not) with EPA. Moreover, since like EPA, apelin treatment 
has beneficial effects on obesity and insulin sensitivity, we also studied the effect of EPA plus 
two weeks of apelin treatment in order to know whether these molecules can have additive or 
synergic effects.  
 
The results obtained in vitro on the effects of EPA on apelin expression in differentiated  
C2C12 myoblastes, showed that a treatment with EPA (50 and 100 µM), especially after 24h 
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of treatment, significantly increased apelin gene expression. The effect of EPA at 100 microM 
was similar to the effect of insulin. As EPA has anti-inflammatory properties, the expression 
of TNFa was also measured. The results show a decrease of TNF-α expression in C2C12 cells 
treated with EPA.  
These are only preliminary results. Further investigations are therefore needed in order to 
evaluate the effects of EPA on the expression of other inflammatory cytokines and to know 
whether the up-regulation of apelin could also be involved in these regulations.  
Beneficial effects of EPA are also correlated to the activation of peroxisome proliferator-
activated receptors (PPARs). An increase in the expression of PPARa was observed after 24h 
EPA treatment only. 
Taken together, the results indicated that, also in muscle cells, EPA induces an increase in the 
expression of the apelin, and its anti inflammatory effect is demonstrated by an decrease of 
TNFα correlated with an increase in expression of PPARα  
 
 
In parallel a study was performed in vivo using male C57Bl6/J mice. The results show that in 
mice fed with a high fat diet rich in EPA there is a lower development of obesity as indicated 
by a decrease in the body weight gain and fat mass compared to HFD mice at the end of 10 
weeks of treatment. Moreover, EPA ameliorates hepatic steatosis. The mechanism by which 
EPA ameliorates the hepatic steatosis could be due to a decrease in SREBPs. These are 
members of transcription factors that regulate fatty acid and cholesterol synthesis (reviewed in 
Brown and Goldstein1). Three isoforms of SREBP, -1a, -1c, and -2, have been identified and 
characterized. The predominant SREBP-1 isoform in liver and adipose tissue is SREBP-1c. 
SREBP-1c regulates not only the synthetic rate of triglycerides but also the amount of their 
storage in the liver.4. Thus, SREBP-1 has been revealed to be a promising target for hepatic 
steatosis (fatty livers). SREBP-1c mRNA expression was decreased in response to EPA and 
could explain the decrease in TG content. However it will be important to measure other 
genes regulated by SREPB1c such as lipogenic genes (fatty acid synthase etc…). This 
decrease in lipid storage in a situation of insulin resistance is usually followed by an increase 
in β-oxidation. However, we did not observe an increase in complete β-oxidation in the liver.  
This result is in contrast with the results showing an increase in fatty acid oxidation in rats fed 
high fat diet in the first experimental series. This can be due to the different experimental 
conditions (animals, periods of treatment, fed/fasting condition) as well as to the different 
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method of measurements (in the whole piece of organ or in isolated mitochondria). Further 
investigations are needed to clarify the mechanism. 
It is known that EPA ameliorate the insulin sensitivity, this is demonstrated in the decreased 
glycemia measured at the moment of the sacrifice in fasted mice and also by serum levels of 
insulin. Moreover the amelioration of insulin sensitivity is correlated with the increase of β 
oxidation.Studies previously conducted by the team, HFD induces an increase in the β-
oxidation in muscle. Surprisingly, the results indicated no difference among the three groups. 
However the mice treated with apelin showed an increase in complete β oxidation. In the 
experimental series 2, I found no differences in fatty acid oxidation and CPT activity in IMF 
mitochondria whereas in SS mitochondria there was an increase in fatty acid oxidation and 
CPT activity both in L and F rats. Taking into account that in this experimental series the 
measurements were done on muscle piece and not on isolated mitochondria and that whole 
muscle metabolism is mainly due to IMF mitochondria, the results are similar to that found in 
IMF mitochondria 
 
However, treatment of EPA mice with apelin during two weeks did not further increase the 
amelioration of the metabolic profile.   
 In parallel apelin expression was measured mainly in skeletal muscle and different 
adipose tissue depots in response to EPA in HFD fed mice. In adipose tissue and in skeletal 
muscle of EPA mice, a slight increase of apelin expression was observed compared to control 
mice. This increase was weaker than in HFD mice. One explanation could be that in vivo 
other parameters could influence the expression of apelin, especially insulinemia. Indeed, 
since in EPA mice insulinemia was reduced compared to HFD mice, it could be that this 
decrease of insulinemia avoids an up-regulation of apelin in the tissues studied. Moreover, fat 
mass was decreased in HFD+EPA mice compared to HFD mice. Thus it is difficult to know 
in vivo whether the effect of EPA on apelin expression in adipose tissue and skeletal muscle 
is direct or indirect and thus a consequence of the amelioration of the metabolic profile. 
However, the in vitro results obtained in C2C12 cells and in the literature on adipose tissue 
are encouraging. Apelin might an interesting target of EPA in mediating its beneficial effects.    
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